




A qualitative study exploring the dynamics of patient adherence to psychotropic 
medication use amongst adult patients with Bipolar Mood Disorder. 




Submitted in partial fulfilment for the requirements for the degree of Master of Social 
Science in Clinical Psychology in the School of Applied Human Sciences, College of 






















I declare that this dissertation is my own unaided work. All citations, references and 
borrowed ideas have been duly acknowledged.  It is being submitted for the degree of Master 
of Social Science (Clinical Psychology) in the School of Applied Human Sciences, 
University of KwaZulu-Natal, Durban, South Africa. 




Signature: ____________________________________  























The Researcher of this study specifically disclaims all responsibility for any liability, loss or 
risk, personal or otherwise, which may be incurred as a consequence, directly or indirectly, of 
































This dissertation is dedicated to: 
My parents, Stephen and Laurie Jane Colton, 
My sister, Sarah Amy Colton,  
My aunt, Robyn Ann Howie, 





























I would like to express my gratitude to the following:   
 My family who supported me in this endeavour and showed immense patience as I 
spent a lot of time and energy on this project,   
 My supervisor,     
 And finally, the participants who took the time and effort to be interviewed and share 
























This study explored the perceived barriers of patient adherence to psychotropic medication 
use amongst adult patients with Bipolar Mood Disorder. Particular attention was paid to the 
personal experiences of each participant in relation to their mental illness, their treatment 
regimen and the private health care system. Two main theories were employed as a means to 
give the questions asked of each participant direction, namely the Theory of Reasoned Action 
and the Theory of Planned Behaviour. These theories were employed as a means to help 
interpret the results of the data gathered since they provide a broad canvas for the exploration 
of health-seeking behaviour. A qualitative approach was used with a semi-structured, 
individual face-to-face interview being conducted with each participant. The data gathered 
from this research was analysed using thematic analysis. Each participant was acquired 
through a private psychiatrist and contacted telephonically by the researcher, who then 
organised a face-to-face interview with each participant in a place of their choice. Each 
interview was audio-recorded with the permission of each participant. A total of 6 
participants took place in this research, comprising of 3 males and 3 females who all met the 
selection criteria for this research. All participants were over the age of 18 years and had been 
diagnosed with Bipolar Mood Disorder (either type I or II) and had been on treatment for 
many years.  
Three core themes emerged from this research: perceived barriers to medication adherence 
(medication side-effects, cost and availability of medication, alcohol and substance use), 
behavioural beliefs and attitudes toward taking medication (psychoeducation from mental 
health care practitioners, phases of illness, societal and social pressure, nature and complexity 
of treatment regimen), as well as self-efficacy (self-learning research, ways of remembering 
medication). Although this research mainly focused on factors that influence non-adherence, 
it also sheds light on the way in which self-efficacy was enabled.  
This study supported previous research conducted regarding non-adherence to medication to 
which factors such as medication side-effects and social stigma were determined to act as 
barriers to adherence, however, this research attempts to explore the personal beliefs and 
attitudes of people who experience these barriers to their mental health treatment regimen on 
a daily basis.  
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This chapter introduces some of the main areas of focus in this research dissertation. 
Highlighted is the issue of non-adherence to psychotropic medication globally and the 
negative impact that medication non-adherence has on the effectiveness of the treatment 
regimen. Furthermore, the two theoretical models employed in this research, namely the 
Theory of Reasoned Action and the Theory of Planned Behaviour shall be briefly introduced. 
The rationale for this research will also be explored followed by an outline of this 
dissertation. 
 
Mental illness is one of the major contributors to the global burden of diseases, and has an 
impact not only on the affected individual and their quality of life, but also on their family 
and caregivers and on the country’s mental health services (Burns, 2011). There are multiple 
pharmacological treatments for mental illness, as well as adjunct treatments in the form of 
psychotherapy, however, due to multiple factors such as resource availability, individual and 
societal perceptions of mental illness, phases of being unwell, side-effects of medication 
etcetera, there is a rising burden of non-adherence in relation to mental health treatment 
regimens and protocols amongst mental health users around the world (Roy, Jahan, Kumari, 
and Chakraborty, 2005). For instance, in a study conducted by McHugh, Whitton, Peckham, 
Welge and Otto (2013), it was found that adults experiencing Unipolar depression and 
anxiety preferred to engage in psychotherapy rather than take psychotropic medication due to 
factors such as medication side-effects. However, in recent years, psychotropic medication 
has become the most common treatment of depression and anxiety due to the rapid 
sublimation of symptoms. McHugh et al. (2013) found that adherence to psychotropic 
medication by their participants over time was poor, as the participants were not engaging in 





Medication non-adherence has several negative effects on the ill individual, their ability to 
function daily as well as on their loved ones. However, much existing research on medication 
non-adherence tends to focus more on chronic medical conditions such as HIV, diabetes, 
cardiac disease and tuberculosis (Van Dyk, 2011; Kolandaivelu, Leiden, O’Gara, and Bhatt, 
2014; Adegbola, Marincowitz, Govender, Ogunbanjo, 2016; Mabitsela, 2012). Thus it is 
necessary to understand the complexity regarding adherence and non-adherence to 
psychotropic treatment in cases of chronic mental illness and explore why non-adherence to 
medication is so common amongst the mentally ill.  
At the opposite end of the spectrum are actions of taking medication for mental or physical 
health known as protective behaviours, which refer to what people do in the belief that their 
behaviour helps to facilitate or protect their health (Tlou, 2009). These beliefs are strongly 
influenced by both individual and societal factors which guide an individual’s intentions and 
thus their actual behaviour and are understood using two models, namely the Theory of 
Reasoned Action and the Theory of Planned Behaviour.  
Theorists Azjen and Fishbein first proposed the Theories of Reasoned Action and Planned 
Behaviour which focus on how attitude can impact on a person’s behaviour, in which attitude 
is a combination of both that individual’s perception of a particular action and also what they 
perceive others to believe about the behaviour (Tlou, 2009). Individual attitude is dependent 
on whether a person views a behaviour in a favourable or unfavourable manner whereas the 
perception of what others believe about a behaviour is determined by whether others approve 
or disapprove of a behaviour. Ultimately a person’s decision to carry out a behaviour is 
weighted by how much importance they place on the subjective opinions of others and if they 
choose to comply with those views. The attitudes of the individual and others ultimately 
decide the intention of the person to either carry out the behaviour or abandon it. These 
theories can be used to help explore the dynamics of medication non-adherence amongst the 
mentally ill regarding how their perception of the importance or unimportance of medication 
in relation to their mental health, as well as how others such as family, friends and society 
perceive mental illness, can influence the intent of an individual to adhere to their medication.   
This dissertation explored the dynamics of patient adherence to psychotropic medication use 
amongst adult patients with Bipolar Mood Disorder. Bipolar Mood Disorder is a chronic 
mental illness which is episodic in nature, in which an affected person experiences shifts in 





episodes include depressive episodes or manic/ hypomanic episodes. Bipolar Mood Disorder 
has two main types, namely Bipolar type I and Bipolar type II, in which Bipolar type I is 
characterised by the occurrence of manic episodes which is a more severe mood state, 
whereas Bipolar type II is characterised by hypomanic episodes (Hirschfeld, Bowden, Gitlin, 
Keck, Suppes, Thase, Wagner and Perlis, 2010). Both forms of Bipolar Mood Disorder can 
experience depressive episodes, however, Bipolar type II experiences more prominent 
depressive episodes whereas mania is more prominent in Bipolar type I (Colin, 2013).  
The psychotropic treatment of Bipolar Mood Disorder involves a combination of medications 
including mood stabilizers such as lithium, antipsychotics, anti-depressants and in some cases 
an anti-epileptic medication is prescribed as well (Avasthi, Kumar and Vikas, 2004). Often 
when the concoction of medications proves to be insufficient in the maintenance of the 
affected individual’s level of functioning, the dosage of each medication is adjusted 
accordingly (Hirschfeld et al., 2010). The process of finding the correct combination and 
dosage of psychotropic treatment is complex and takes time, as with all mental illness, 
psychotropic treatment has to be tailored to the specific individual and their illness 
presentation (Avasthi, Kumar and Vikas, 2004). According to Hirschfeld et al. (2010), other 
forms of management that can be used in combination with the pharmacological treatment of 
Bipolar Mood Disorder including electro-convulsive therapy (ECT), psychosocial support 
structures as well as psychotherapy and group psychotherapy (Hirschfeld et al., 2010).  
The participants of this research were heterogeneous in that both types of Bipolar Mood 
Disorder, namely type I and type II were included. All of the participants were private mental 
health care users. Furthermore, participants in this research had been on psychotropic 
treatment for years. This factor was necessary to this research due to the complex treatment 
regimen used in Bipolar Mood Disorder which is dependent on a best fit titration of 
medication based on the mood states of the individual. As such, finding a best fit titration of 
medication takes time to ‘perfect’. This was to ensure that all participants in this research 
were on a stable treatment regimen on which they had time to both adhere and in the case of 
this research, non-adhere to their medication. This was also to ensure mood stability at the 









1.2.Rationale for this Research  
Ceasing or irregularly taking anti-depressant or antipsychotic medication can have serious 
physical and mental side-effects due to what is known as “discontinuation syndrome” 
(Ackroyd, 2005). According to Ackroyd (2005), the physical side-effects of stopping anti-
depressant and antipsychotic medication include vomiting, nausea, headaches and 
restlessness whereas the mental side-effects include agitation and irritability, emotional 
outbursts including crying and suicidal thoughts, insomnia, sensory disturbances as well as 
cognitive impairment. This is due to the fact that anti-depressant and antipsychotic 
medications should not be stopped abruptly or taken randomly but instead, gradual reduction 
of the amount of the anti-depressant or antipsychotic drug must be taken in order to avoid 
discontinuation syndrome to occur and the symptoms associated with this syndrome. As such, 
it is important for individuals on treatment for mental illness to be aware of the danger 




















Furthermore, mental health care services and facilities are inadequately available within 
South Africa and whilst advances have been made in our health care system, the mental 
health care system has been left neglected with few resources being available to our public 
both within the private and public sectors of health (Burns, 2011). According to Hassim 
(2007), psychiatric illnesses contribute to 14% of diseases worldwide, yet despite this high 
percentage of the occurrence of mental illness, many medical aid schemes limit psychiatric 
benefits within the private sector. This is evidenced in how access to certain medications for 
the treatment of mental illnesses are limited depending on which medications are listed on the 
“Essential Drug List” by medical aid schemes, resulting in some medications not being 
covered and paid for by a person’s medical aid. Difficulties with regard to cost and 
availability of medication acts as a barrier to health seeking behaviour in which seeking care 
is delayed (Institute of Medicine, 2002).  
According to Hassim (2007), there are even fewer mental health resources available in the 
public sector. Few psychiatrists are being hired in the public sector, but also many primary 
health care clinics within communities do not have the resources to treat psychiatric illnesses 
and there is limited access to clinics that do treat mental illness. As such, this research will 
help bring awareness to the mental health care gap which needs attention not just within our 
country but globally as well. This research will also focus specific attention to the private 
health care sector and assist in understanding the dynamics that affect adherence to 
psychotropic medication amongst private mental health care patients. 
Mental illness is still an area of health that is subject to much stigma in which individuals fear 
the scrutiny and judgment associated with requiring psychotropic medication to help them 
with their overall functioning (Hassim, 2007). This research will help to bring awareness to 
the effect that stigma has on medication adherence and on the affected person in general.  
In exploring some of the dynamics which impact medication adherence, it was envisaged that 
this research would identify some of the significant dynamics that impact on treatment 









1.3.How will the Research Attempt to Understand the Problem?  
This research will uncover the potential dynamics of non-adherence to medication for the 
treatment of Bipolar Mood Disorder. If modifiable factors are determined, the aim would be 
to establish interventions that highlight and educate the dangers of non-adherence, as well as 
make recommendations that facilitate and promote adherence to medication. In essence, the 
research will be the driving force to identify the problem areas that will target a reduction in 
patient non-adherence to medication for the treatment of Bipolar Mood Disorder. This 
research is also part of a larger research project on non-adherence and whilst it is not the 
scope of the present research, the practitioners’ perspective would also enhance our 
understanding of factors that affect non-adherence.  
 
1.4.Outline of this dissertation  
In Chapter one of the dissertation, a background to the problem of non-adherence to 
medication is provided as well as an understanding of what Bipolar Mood Disorder is and 
how it is pharmacologically managed. This chapter also includes the rationale for conducting 
the current study and the aims and objectives of the research. 
Chapter two consists of a thorough review of the literature on Bipolar Mood Disorder, non-
adherence and the impact of non-adherence on wellness. The chapter concludes with a 
theoretical framework, the theory of reasoned action and theory of planned behaviour, 
explaining the mechanisms of non-adherence, and a hypothesis on why Bipolar Mood 
Disorder individuals are sometimes non-adherent to their medication.    
Chapter three presents the study's research methodology, challenges and issues of 
trustworthiness.    
Chapter four presents the study's findings, and includes direct quotes from the participants in 
this research.    
Chapter five presents an interpretation of the findings of this study in relation to the Theory 
of Reasoned Action and the Theory of Planned Behaviour and existing research. 







1.5.Summary of Chapter 
To summarise, this chapter introduced some of the main areas of focus in this research 
dissertation. Highlighted were the issues of non-adherence to psychotropic medication 
globally and the negative impact that medication non-adherence has on the effectiveness of 
the treatment regimen. Furthermore, the two theoretical models employed in this research, 
namely the Theory of Reasoned Action and the Theory of Planned Behaviour were briefly 
introduced. The rationale for this research was explored followed by an outline of this 
dissertation. In the next chapter, i.e. chapter two, an extensive review of the literature already 



























A literature review entails investigating a body of knowledge already existing within a field 
of interest (Mouton, 2013). This review begins with describing the physiology of Bipolar 
Mood Disorder and its impact on the affected persons. The types of pharmacological 
treatments for Bipolar Mood Disorder shall also be discussed. This will be followed by the 
prevalence and impact of non-adherence to medication amongst individuals on chronic 
medication and its outcome on their wellness. Some of the factors impacting on medication 
adherence shall also be explored. Finally, the study has drawn on theories from the field of 
Health Promotion, i.e. the Theory of Reasoned Action and the Theory of Planned Behaviour 
to assist in conceptualizing the multifaceted nature of treatment adherence. 
 
2.2. Nature and Scope of the Problem  
According to Tomlinson, Grimsrud, Stein, Williams and Myer (2009), mental disorders 
contribute to about 14% of disease in all regions of the world. Bipolar Disorders have been 
recognised by the World Health Organisation (2004) as being a leading cause of 
incapacitation in 17.6% of individuals under 59 years old in low and middle-income 
countries, much like South Africa. A problem identified has been that despite effective 
treatments in the form of medications and professional interventions available to treat mental 
illnesses including Bipolar Mood Disorder, many individuals’ have increasing levels of non-
adherence towards their prescribed treatment regimens (Roy et al., 2005). In a study 
conducted in Ranchi, India by Roy et al. (2005), the average level of poor adherence to 
medication amongst the mentally ill ranged from 30 – 35% in relation to all mental illness 
states. This non-adherence to medication has consequences on the ill individual, their mental 
and physical health, their relation to loved ones, the health care system and society at large 






Research question: What are some of the factors that contribute towards   poor patient 
adherence to Bipolar Mood Disorder medication treatment regimens? 
 
2.3. What is known so far? 
2.3.1. The Pathophysiology of Bipolar Mood Disorder  
According to Berns and Nemeroff (2003), Bipolar Mood Disorder is an episodic condition in 
which an affected person experiences abrupt phases of being unwell until returning to a 
relatively normal state. These episodes of being unwell take the form of a depressive episode 
or a manic/ hypomanic episode. Bipolar Mood Disorder is divided into two types, namely 
Bipolar I and Bipolar II, in which Bipolar type I is characterised by manic episodes whereas 
Bipolar type II is characterised by hypomanic episodes (Hirschfeld et al., 2010). Both forms 
of Bipolar Mood Disorder can experience depressive episodes, however, Bipolar type II 
experiences more prominent depressive episodes whereas mania is more prominent in 
Bipolar type I (Colin, 2013). According to Vieta (2014), mania is a complex mood state in 
which a rapid change in a person’s behaviour occurs including elevated energy levels which 
goes in hand with a reduced need for sleep, increased goal-directed behaviours, impulsivity 
and irritability. Symptoms of mania last for at least one week (Hirschfeld et al., 2010). The 
table below by Vieta (2014) lists the symptoms which may be experienced by individuals 
experiencing a manic episode and these symptoms can affect the persons’ mood, cognition, 
activity and behaviour or even take the form of psychosis: 
 
Table 2.1 – Symptoms of Mania 
(Vieta, 2014, pg 3).  
Mood: Cognition: Psychosis: Activity/ Behaviour: 
Irritability Grandiosity Any delusions 
including: 
Hyperactivity 
Euphoria Flight of ideas Grandiosity Decreased need for sleep 
Depression Distractibility – poor 
concentration 
Persecutory paranoia Violent assault behaviour 
Mood lability Confusion Any hallucinations 
including: 
Rapid pressured speech 
Expansiveness  Auditory/ Visual  Hyper verbosity 





Mania can have two presentation types, namely euphoric mania in which the persons’ mood 
is elevated and expansive, and irritable mania in which the mood may be aggressive and 
agitated (Vieta, 2014). These symptoms must last for at least one week for a diagnosis of 
Bipolar Mood Disorder type I to be made (Colin, 2013).  Mania can be extremely debilitating 
to the individual as during this time functionality in most spheres of their life such as work or 
school, relationships and finances are affected. 
According to Vieta (2014), hypomania is a mild to moderate form of mania, however, no 
psychotic symptoms occur and the individual may still be able to function during their 
hypomanic phase. Symptoms of hypomania are similar to those in mania, however, the 
duration of the symptoms must occur for at least 4 days in order for a diagnosis of Bipolar 
Mood Disorder type II to be made. The symptoms of hypomania in affected individuals often 
do not impair their daily functioning, and in some instances are experienced as enjoyable, to 
which individuals may experience a pleasant mood state, a good sense of humour and high 
productivity levels (Michalak, Yatham, Kolesar & Lam, 2006). However, hypomania can 
have profound effects on the person as things they say or do during this mood state cannot 
always be repaired or taken back. Furthermore, hypomania can develop into a manic episode 
or it may precede a depressive episode to which the symptoms are severe. 
A Major Depressive Episode (MDE) can occur in both types of Bipolar, however it is more 
prevalent in Bipolar type II. These episodes are characterised by a low mood and loss of 
interest and pleasure lasting for at least two weeks (Michalak et al., 2006). Other symptoms 
of a major depressive episode include lethargy, difficulties concentrating, troubles with sleep, 
changes in appetite as well as thoughts or attempts at suicide (Hirschfeld et al, 2010). Table 
2.2 by Vieta (2014) lists the symptoms which may occur in individuals experiencing a major 
depressive episode:    
 
Table 2.2 – Symptoms of a Major Depressive Episode (MDE) 
 
Signs and Symptoms of a Major Depressive Episode 
Lasting sadness, anxious or empty mood  
Feelings of hopelessness or pessimism  





Loss of interest or pleasure in once pleasurable activities including sex 
Decreased energy, fatigue or being slowed down  
Restlessness and irritability  
Sleeping too much or unable to sleep  
Change in appetite and/ or weight loss/ gain  
Chronic pain or other physical symptoms not caused by illness or injury  
Thoughts of death or suicide, or suicide attempts 
 
(Vieta, 2014, pg 4).  
 
Bipolar Mood Disorder can be reliably diagnosed by a mental health care practitioner and a 
combination of psychotherapy, social support and medications have been found to be 
effective in the treating of the major symptoms (Marcus et al., 2012). Despite the availability 
and effective nature of medication in the maintenance of the symptoms of Bipolar Mood 
Disorder, a prevalence for non-adherence to medication amongst people with Bipolar Mood 
Disorder has been found due to adherence being highly dependent on the motivation and self-
efficacy of the patient (Chowdhury, Patel, George and Callahan, 2013). This motivation and 
self-efficacy of the patient can and will be linked to two major theories in this research, 
namely the Theory of Reasoned Action and the Theory of Planned Behaviour, which shall be 
discussed in further detail.  
 
2.4.Theoretical Frameworks of Health Behaviour  
Before understanding what motivates a person’s health behaviour, it is important to 
understand what health behaviour is. According to Tlou (2009), health behaviour is any 
activity that a person performs in order to help maintain or improve their health. This 
definition can be expanded to include health protective behaviour which refers to what people 







2.4.1. The Theory of Reasoned Action  
The Theory of Reasoned Action (TRA), was created by Martin Fishbein and Icek Ajzen and 
was built on the theoretical tradition that considered attitudes as a major influence on human 
behaviour (Tlou, 2009). According to Vallerand, Pelletier, Mongeau, Deshaies and Cuerrier 
(1992), the Theory of Reasoned Action focuses on how the engagement in certain behaviour 
by a person is motivated by two major factors, namely their attitude toward the behaviour as 
well as a social component, known as subjective norms, which is what other people believe 
he or she should do. Attitude toward the behaviour can be defined as “accessible or salient 
beliefs about the likely outcomes of performing the target behaviour”, whereas subjective 
norms can be defined as “the perceived social pressure to perform or not perform the target 
behaviour” (Nisson and Earl, n.d, pg: 2). According to Nisson and Earl (n.d) the perceived 
likelihood of an individual performing a particular target behaviour is known as the 
behavioural intention. An individual’s attitude toward a specific behaviour is believed to be 
motivated by their evaluation of its consequences or outcome whereas the social component 
is more based toward others’ expectations and advice on what should be done and as such the 
individual may choose to comply with the directions of these social others (Vallerand et al., 
1992).  Adding to the complexity of understanding human behaviour is the notion of 
perceived behavioural control, which refers to one’s perception of their ability to enact the 







































The Theory of Reasoned Action has been found to be a relatively successful predictor of 
health intentions and behaviour, however, in certain situations behaviour is not only 
determined by attitude and personal motivation but also other factors such as biological 
aspects, access to treatment and health service as well as financial difficulties (Nisson and 
Earl, n.d). These factors shall be explored in more detail later into the literature review.  
Although the Theory of Reasoned Action was originally created to try and understand as well 
as “predict” behaviour, this theory is also useful in helping to identify important target areas 
for intervention in order to try and change health behaviours. 
 
2.4.2. The Theory of Planned Behaviour 
  
According to Cameron (2010), the Theory of Planned Behaviour focuses on how behaviour is 
largely determined by a person’s behavioural intention which is influenced by their attitude 
toward a behaviour, the subjective norms surrounding the behaviour and the person’s 
perception of their control over the behaviour. This theory explores factors that both motivate 
and influence human behaviours, including health behaviours (Rhodes and Courneya, 2003). 
According to Rhodes and Courneya (2003), one of the most important factors influencing a 
person’s behaviour is their intent or choice to engage in such an action and such choices are 
greatly influenced by each individual’s subjectivity and attitude. A person’s attitude refers to 
their evaluation of a particular behaviour whereas subjectivity, or rather subjective norms 
refer to an evaluation of the behaviour and whether the individual is pressured to either 










Figure 2.2: The Theory of Planned Behaviour taken from Cameron (2010, pg 3). 
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2.4.3. Limitations of the Theory of Reasoned Action and the Theory of Planned 
Behaviour 
 
Tlou (2009) states that both the Theory of Reasoned Action and the Theory of Planned 
Behaviour have some limitations. Both theories fall within the cognitive behavioural realm 
which assumes that all human beings have the ability to reason and that reasoning allows one 
to make decisions regarding one’s behaviour. However, during certain states of being 
mentally unwell, a person with mental health issues may have impaired reasoning and as 
such, these two theories do not always apply. Furthermore, the Theory of Reasoned Action 
and the Theory of Planned Behaviour both take an individualistic stance in which behaviour 
and decision-making processes are seen to be within the internal locus of control of the 
individual. The role of social influence and pressure is often minimised despite individual 
evaluations of the opinions and beliefs of significant others being an important factor in the 
decision-making process.  
 
2.5.What is Adherence and Non-Adherence?  
According to the World Health Organisation (2001), the term “adherence” can be defined as 
“the extent to which a persons’ behaviour – taking medication, following a diet, and/ or 
executing lifestyle changes, corresponds with agreed recommendations from a health care 
provider”. On the other hand, non-adherence can be defined as “a patient’s passive failure to 
follow a prescribed therapeutic regimen” (Latif and McNicoll, 2009). This definition of 
adherence greatly differs from the term “compliance” which entails the passive following of 
instructions given by a health care practitioner to take one’s medication, thus implying that 
the consumption of the medication is not an independent or informed choice of the patient 
(Chowdhury, Patel, George and Callahan, 2013).  
Medication non-adherence has become a growing concern within the health care field, 
including in the treatment of medical conditions such as hypertension (Wetzels, Nelemans, 
Van Wijk, Broers, Schouten and Prins, 2006). According to the World Health Organisation 
(2013), approximately 50-70% of hypertensive patients globally do not adhere with their anti-
hypertensive medication as prescribed and recommended. Within South Africa, this non-
adherence to anti-hypertensive medication is a common phenomenon despite availability to 





1995). Such non-adherence has found to be a realistic problem in a range of other health 
concerns such as the use of anti-retroviral medication for the treatment of the Human 
Immunodeficiency Virus (HIV). According to Van Dyk (2011), as of 2004, South Africa has 
the largest national anti-retroviral treatment programme in the world. Despite the availability 
of treatment programmes to the public, a lack of non-adherence to antiretroviral medication 
amongst HIV-positive patients in South Africa remains a problem that has serious health 
implications, including the formation of resistance to treatment, causing the infection to 
spread and thus implicating the survival rate of the infected person. Valjee (2000) conducted 
research among adults with multi-drug resistant tuberculosis in which it was recognised that 
despite the availability of medications used to treat tuberculosis, South Africans have 
developed a norm for defaulting on their medication. Thus it is evident that amongst many 
health conditions, non-adherence is a common issue.   
 
2.5.1. Non-Adherence Amongst People with Bipolar Mood Disorder 
 
According to Chakrabarti (2016), about half of people diagnosed with Bipolar Mood 
Disorder become non-adherent at some point during their long-term treatment. A multitude of 
factors impact on the adherence rate of individuals with Bipolar Mood Disorder, however, 
most research tends to only focus on demographics and medical-related factors influencing 
adherence. Non-adherence to medication in Bipolar Mood Disorder has many adverse effects 
on the usefulness of the treatment, and increases the risk of relapse, hospitalisation and 
suicide. Furthermore, non-adherence results in the greater utilisation of health-care services 
and thus an increase in mental health expenditures. There are further consequences of non-
adherence on the individuals’ quality of life, stigmatisation, functional impairment and the 
need for care from family and friends.  
 
Other factors affecting adherence rates amongst people with Bipolar Mood Disorder include 
dosing regimen, medication side effects, the fear of becoming addicted to medication as well 
as concerns regarding drug interactions (Ibrahim, Pindar, Yerima, Rabbebe, Shehu, Garkuwa, 
Bashir, Wakil and Yahya, 2015). According to Ibrahim et al. (2015), most studies exploring 
non-adherence to medication looked at patient-related socio-economic factors, with little 
research focusing on medication-related factors regarding rates of non-adherence. In a study 





adherence amongst people with Bipolar Mood Disorder and Schizophrenia included the cost 
of medications, medication combinations, dosing frequency and medication side effects. 
These factors shall be explored in further detail into this literature review.  
 
According to Chakrabarti (2016), the rate of non-adherence amongst people with Bipolar 
Mood Disorder has increased over the years despite many new and different medications 
being introduced. The rate of non-adherence to medication amongst people with Bipolar is 
currently on par with several other chronic mental and medical disorders such as 
Schizophrenia, diabetes and high blood pressure.  
 
 
2.6.Treatment of Bipolar Mood Disorder 
Amongst individuals with Bipolar Mood Disorder, the main pharmacological treatments 
involve a combination of drugs including mood stabilizers such as lithium, antipsychotics, 
anti-depressants and in some cases an anti-epileptic drug is prescribed as well (Hirschfeld et 
al., 2010). Often when the concoction of medications proves to be insufficient in the 
maintenance of the affected individual’s level of functioning, the dosage of each medication 
is adjusted accordingly. According to Hirschfeld et al. (2010), other forms of management 
that are used in hand with the pharmacological treatment of Bipolar Disorder include electro-
convulsive therapy (ECT), psychosocial support structures as well as psychotherapy and 
group psychotherapy. Most recently, psychiatrists have been exploring new types of 
treatment for Bipolar Mood Disorder including the use of Ketamine, which has been found to 
produce quick, yet short lasting relief of depressive symptoms in Bipolar patients (Iosifescu, 
2015). Although there is no cure for Bipolar Mood Disorder, such treatments allow for the 
stabilisation of the mood patterns of affected person’s and can greatly reduce the high 10 – 
15% suicidality that has been calculated amongst those with Bipolar Mood Disorder 
(Hirschfeld et al., 2010).  
 
 
2.7. The Rising Burden of Non-Adherence among Patient’s with Bipolar Disorder 
Adhering to medication prescribed for the treatment of any mental illness is highly pertinent 
and positively correlated with the improvement in one’s level of health and functioning (Roy 





factor in all areas of medical health, with mental illness being no exception to this rising 
problem. Thus poor or non-adherence can be cited as an integral cause of uncontrolled and 
untreated Bipolar Disorder as well as a re-entering of affected persons’ into mental health 
care facilities. This highlights the need to improve control of Bipolar Disorder to prevent 
premature death due to high suicidality rates among Bipolar persons’ as well as to prevent the 
general degradation in their quality of living.  
 
 
2.8.Dynamics of Non-Adherence Regarding Medication and Lifestyle Regimens 
Non-adherence is a complex, multidimensional phenomenon which involves various factors 
both unique and context specific to the individual, which contribute to non-compliance. 
Some of the reasons for non-adherence to medication include:  
 
 
2.8.1. Medication Side-Effects 
In a study conducted amongst 100 subjects between 2002 and 2003 in India, one of the major 
contributors to a lack of adherence to medication was due to the side-effects experienced as a 
result of anti-depressant medication (Roy et al., 2005). According to the Agency for 
Healthcare Research and Quality Advancing Excellence in Healthcare (2007), some of the 
major side-effects of anti-depressant medications include excessive weight gain, diarrhoea, 
nausea, dry mouth, dizziness, troubles with sleeping at night, sleepiness during the daytime, 
headaches, shaking and even sexual dysfunction. These symptoms can often act as a deterrent 
to Bipolar persons’ from taking their medication. However, multiple types of anti-depressants 
are available and as such, individuals’ with Bipolar Disorder, in conjunction with a 
professional such as a psychiatrist or medical doctor, have the ability to identify an option 
that works best for them and has minimal side-effects.  
According to Stafford (2011), lithium is a commonly used medication for the treatment of 
Bipolar Disorder, however, both short-term and long-term side-effects associated with this 
drug act as major causes of non-adherence amongst people with Bipolar Disorder. Short-term 
side-effects include an upset stomach, tremors of the hands and legs, excessive thirst, the 
need to urinate frequently, unsteadiness on one’s feet as well as fatigue. The long-term side-
effects of lithium, which often persist months after taking the medication, include excessive 





which are often an annoyance include a metallic taste on the tongue that alters the taste of 
food. Finally, but most worrying of the side-effects includes fluid retention, visual 
impairment, deregulation of the heart beat (arrhythmia), memory loss, seizures and even 
Parkinson’s disease. It is thus understandable as to why such side-effects may act as a 
deterrent to adherence to one’s medication.  
Another commonly used medication for the treatment of Bipolar Mood Disorder includes an 
anticonvulsant which also has side-effects such as dizziness, drowsiness, fatigue, nausea, 
tremors and weight gain, as well as some severe side-effects including an increased risk of 
suicide and life-threatening skin rashes (Health.org., 2011). Finally, antipsychotic 
medications for the treatment of Bipolar Disorder have been found to include a long list of 
side-effects such as vomiting, dizziness, tics and tremors, dry mouth, seizures, weight gain, 
nausea, restlessness, constipation and even low white blood cell counts which impacts on the 
body’s ability to fight off infections (Agency for Healthcare Research and Quality, 2013).  
In a study conducted by Ibrahim et al. (2015), it was found that individuals on treatment for 
Bipolar Mood Disorder whom experienced side-effects from their medication were seven 
times more likely to be non-adherent in comparison to those who experienced no medication 
side-effects. This was found to be due to the impairment in quality of life associated with 
having negative medication side-effects as well as the interference side-effects have on their 
ability to carry out activities of daily living.  
 
Illustrated in the table below is a list of medications used in the treatment of Bipolar Mood 
Disorder and their side-effects:  
 
Table 2.3 – Medications Used in the Treatment of Bipolar Mood Disorder and their Side-
Effects 
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2.8.2. Dosing Frequency of Medication  
 
According to a study by Ibrahim et al. (2015), dosing frequency was found to be the main 
predictor of medication non-adherence amongst individuals with Schizophrenia and Bipolar 
Mood Disorder. Individuals with multiple dosages of medication per day were eight times 
more likely to be non-adherent to their medication than those who had fewer daily dosages. 
Some of the main reasons for the relationship between dosing frequency and non-adherence 
included forgetting to take the medication, medication side-effects such as sedation and 
impairment in cognition as well as the discomfort of having to take medication multiple times 






The relationship between dosing frequency and non-adherence does not only exist amongst 
individuals on treatment for mental illness, but in many other medical conditions too. In a 
study conducted in Singapore by Toh, Teo, Kwan, Raaj, Tan and Tan (2014), it was found 
that multiple dosages of medication per day resulted in greater amounts of non-adherence and 
more hospital admissions amongst individuals with chronic conditions such as high blood 
pressure. Similarly, in a study by Coleman, Limone, Sobieraj, Lee, Roberts, Kaur and Alam 
(2012), it was found that individuals with chronic medical conditions had greater levels of 
adherence to medication when the dosing frequency was once daily. Individuals with 
medication dosages occurring twice or three times daily were found to have higher rates of 
medication non-adherence. However, even individuals whom only had to take medication 
once daily were found to sometimes be non-adherent to their treatment, indicating that there 
are other factors which contribute to medication non-adherence. Some of these factors shall 
be further explored. 
 
 
2.8.3. Patient Perceptions, Beliefs and Attitudes 
 
2.8.3.1.Anxiety Regarding Long-Term Efficacy of Treatment 
 
According to Roy et al., (2005), another contributing factor to non-adherence to medication 
amongst the mentally ill is due to their perception that taking such medications will result in 
immunity to its effects and thus will result in larger doses being required; in other words, 




Other perceptual factors involve the social stigma Bipolar Disordered persons’ feel is 
attached to requiring medication for the treatment of their mental illness and thus they fear 
the scrutiny and judgment associated with requiring a drug to help them with their overall 







2.8.3.3.Impairment in Functioning 
 
Another major issue introduced to non-adherence to medication is the perception that many 
mental illnesses impair one’s overall level of mental functioning, reasoning, judgement and 
stability which too could hinder their level of compliance (Centre for Disease Control and 
Prevention, 2012).  
 
2.8.3.4.Religious and Cultural Beliefs  
 
An important factor recognised with regard to perceptions included religious and cultural 
beliefs surrounding the use of medications to treat their mental illness (Roy et al., 2005). For 
instance, according to Starkowitz (2013), 80% of people in South Africa would prefer to visit 
a traditional healer for alternate forms of medicinal treatment rather than visit a medical 
doctor or mental health care practitioner. Some of the reasons expressed by our country’s 
population as to why traditional healers are a preferred source of treatment include a higher 
accessibility of traditional healers within our country as well as that they are more cost 
efficient. Traditional healers are also seen to have a more holistic approach to treatment in 
that they focus on the psychological, spiritual and environmental factors which influence and 
impact on a person.  
In relation to mental health care in particular, traditional healers have been a source of 
treatment for mental illness for centuries in South Africa, whereas psychiatry and psychology 
are fairly new fields of practice in our country, with many of its means of treatment being 
based on a Westernised society which does not always fit the needs of our country’s people 
(Starkowitz, 2013). This is due to the fact that culture is a strong determining factor for how a 
person experiences and shows emotional distress and illness, meaning that a person in a 
Westernised society may experience and exhibit different symptoms of a mental illness than 
that of someone in South Africa. 
 
2.8.3.5.Perception of Mania 
 
Adding to the dynamic of patient non-adherence to medication is the patient perception of the 





individuals’ do not wish to suppress these symptoms by taking their medication (Boyd and 
Dunn, 2015). As a means to explain this, a quote by an individual with Bipolar Disorder 
stated that the mania acts as an “emotional amplifier: when my mood is high I feel far 
quicker, funnier, smarter, livelier than anyone”. Having a manic episode can sometimes feel 
exciting and fun in which the individual feels euphoric, special and untouchable. In another 
quote from Boyd and Dunn (2015), an individual with Bipolar Disorder states that the trick is 
to try and not be seduced by the mania, thus illustrating the desire that some people feel to 
remain manic. This may result in non-adherence to their medication as a means to maintain 
their “high”.  
 
2.8.3.6.Nature and Complexity of Treatment Regimen and Self-Learning 
 
A further aspect contributing to medication adherence and non-adherence is individual 
knowledge regarding ones’ condition and the perception of the importance of taking ones’ 
medicine. In a study conducted by Ben-Natan, Salama, Khalaily and Adler (2013), if an 
individual believes that medications are important and should be administered; this will be 
manifested in their behaviour and thus encourage a higher rate of adherence to medications. 
These beliefs about medication importance are acquired based on one's life experience and 
knowledge of a certain topic, leading to the formation of opinions and impacting one's 
reasoning about a specific behaviour.  
Much of an individual’s initial knowledge into their mental disorder and their understanding 
of the importance of their medication should come from the practitioner who diagnosed them, 
however, according to the Treatment Advocacy Centre (2014), a poor therapeutic alliance 
between patient and practitioner may result in a practitioner not taking the time to explain a 
diagnosis and medication to the patient. This could contribute to non-adherence as the patient 
is often left unaware of the importance of and why they need medication. Furthermore, not 
fully understanding the purpose of medication could also lead to compliance, in which the 
patient takes their medication strictly because their doctor told them to, and this results in 








2.8.4. Socio-Economic Factors  
According to Burns (2011), mental disorders are responsible for numerous concerns 
including increased mortality in the form of suicide, reduced life expectancy; for individual 
and collective suffering; for significant loss of social and occupational functioning, disability 
and an extensive burden on family and other caregivers. Yet despite all of these factors, 
mental health care services and facilities are inadequately available within South Africa 
(Burns, 2011; Stein, 2014; Parker, 2014; Gillis, Robertson, Zabow and Stein, 2012). Whilst 
advances have been made in our health care system, the mental health care system has been 
left neglected with few resources being available to our public (Burns, 2011).  Within South 
Africa, the average number of psychiatrists is approximately 0.05 per a 100 000 population as 
compared to high income countries which have an average of 10.5 psychiatrists per a 100 000 
population. Not only within South Africa but globally, mental health services receive a much 
smaller proportion of funding in comparison to other health sectors, in which mental health is 
often considered a low priority.  
Within South Africa, approximately 86% of health services are provided through the public 
health care sector, however, only 50% of health expenditures are covered by tax-funded 
money from the government (Health Policy Project, 2016). This means that the remaining 
50% of payment for public health care services is the responsibility of the health care seeker, 
despite public health services mostly being used by low income individuals who can ill afford 
the costs of medical treatment. The private health sector consists of approximately 16% of the 
South African population whom are mostly individuals with a middle to high income 
financial background who can afford to be on medical aid schemes which assist in paying for 
certain health care treatments.  
South Africa has approximately 86 different medical aid schemes which medical aid 
members pay for in order to cover the costs of many types of health care, however, medical 
aid schemes do not cover the total costs of all treatments, to which residual monetary 
amounts come out the pocket of the medical aid member (Ncayiyana, 2012). According to 
Ncayiyana (2012), pharmaceuticals are the most claimed for from medical aid schemes, with 
some medications having exorbitant residual fees for the medical aid user to pay themselves. 
However, the same medications can usually be prescribed and given in the public health care 
sector at a much lower cost. This evidences how medical health care schemes in South Africa 





Despite there being pitfalls in our health care system, South Africa does however have a 
progressive mental health legislation with the purpose of providing the following: 
 Access to mental health care including access to the least restrictive care;   
 Rights of mental health service consumers, family members, and other care givers;   
 Competency, capacity, and guardianship issues for people with mental illness;   
 Voluntary and involuntary treatment;   
 Accreditation of professionals and facilities;  
 Law enforcement and other judicial system issues for people with mental illness;   
 Mechanisms to oversee involuntary admission and treatment practices; and   
 Mechanisms to implement the provisions of mental health legislation (World Health 
Organisation, 2007, pg 8). 
 
Due the financial constraints and in some cases blatant mismanagement of psychiatric care 
facilities in South Africa, such as in the Life Esidimeni Case in which former mentally ill 
residents had their Mental Health Care Rights breached when they were discharged from the 
facility to multiple Non-Government Organisations (NGO’s), in which following their 
discharge 94 people died (Makgoba, 2017), audits of psychiatric care in the public domain 
have been criticised for the following: 
 Psychiatric hospitals remaining outdated and often unfit for human use; 
 Serious shortages of mental health professionals; 
 An inability to develop vitally important tertiary level psychiatric services (such as 
child and adolescent services, psychogeriatric services, neuropsychiatric services, 
etc.) and; 
 Community mental health and psychosocial rehabilitation services remaining 







2.8.4.1.The Impact of Poverty on Adherence 
 
 
Approximately 50% of South Africa’s population live below the poverty line, with 
individuals from lower income households often finding medicine for their mental illness a 
cost that they can ill afford (Burns, 2011). According to Statistics South Africa (2014), the 
severity of poverty in South Africa has worsened, with approximately 4,75 million 
households in South Africa living below the poverty line. Within the lower economic 
groupings in South Africa, majority of people from rural areas seek out traditional means of 
treatment rather than having to pay the cost of receiving care and medicine from professional 
health care practitioners (Burns, 2011). According to Sorsdahl, Stein, Grimsrud, Seedat, 
Flisher, Williams and Meyer (2009), approximately 41-61% of South Africans with mental 
illness have consulted a traditional healer, with 26% seeking the help of a traditional healer 
first before going to see a professional mental health care practitioner due to higher 
availability of traditional healers and more affordability.  
Non-adherence amongst individuals with Bipolar Mood Disorder is evidently an important 
issue which requires attention within our country but also globally. The risk of non-adherence 
has individual, social and societal impacts, however, the specific barriers to medication 
adherence in South Africa have not been explored in their entirety. These barriers need to be 
identified and thoroughly explored in order for them to be addressed.  
 
 
2.9.Summary of Chapter 
This chapter described the physiology of Bipolar Mood Disorder and its impact on the 
affected persons. The types of pharmacological treatments for Bipolar Mood Disorder were 
also discussed followed by the prevalence and impact of non-adherence to medication 
amongst individuals on chronic medication. Finally, the Theory of Reasoned Action and the 
Theory of Planned Behaviour were explored. The next chapter focuses on the methodology of 















Research methodology concerns itself with the methods and procedures used when particular 
phenomena are under investigation (Mouton, 2013). The focus is on the research process as 
well as the kind of tools used by the researcher to answer the specific research questions. This 
chapter begins by providing an overview of the research design used to achieve the aims of 
the study, followed by an explanation on the selection of participants. The research 
instrument as well as the data collection method will also be discussed in detail after which 
an explanation of the data analysis is employed. The chapter concludes with a reflection 
section as well as a section on the reliability of this study and how this study attempted to 




A research design refers to a plan of how the researcher intends to conduct the research 
(Mouton, 2013). A way in which research starts is through a research question and how the 
researcher intends to answer the research question through finding evidence. The type of 
research design that a researcher chooses should fit with the aims and goals of the research 
and should not be chosen based on the researchers’ design preferences.  
This study was based on the thematic paradigm. According to Braun and Clarke (2006) 
thematic analysis is a method for identifying, analysing and reporting patterns or themes 
within the data. Themes are defined as a specific pattern found in the data in which one is 
interested in. Thematic analysis is the searching across a data set to find repeated patterns of 
meaning. Thematic analysis is an appropriate method for first time researchers who are not 





how she/he thinks it connects. Braun and Clarke (2006) proposed a 6 phase guide that can be 
used when doing thematic analysis. These include:  
a) Familiarising oneself with the data- through the process of transcribing, reading and re-
reading the data which allows the identification of initial themes that exist. 
b) Generating initial codes or themes- grouping different aspects of the data into codes in 
the fashion that they relate to one another, by going systematically through each item in 
the data. 
c) Searching for themes- this involves sorting the different codes into potential themes and 
collating all the relevant coded data extracts within the identified themes. 
d) Reviewing themes- combine and document related patterns into sub-themes; looking 
for coherent and themes that need to be discarded or revised. 
e) Defining and naming themes- build a valid argument for choosing the themes by 
defining what each theme mean, captures and identify what is interesting about them.  
f) Writing up the report- this involves the final analysis of the results and making an 
argument in relation to your research questions and informing theory. 
 
An exploratory, cross-sectional research design was used for this particular study. This means 
that the data collected from the target population of this research was analysed at one specific 
point in time. The results from a cross-sectional research design come from a population with 
specific characteristics and can be used to describe the prevalence of the research problem in 
said population as well as to describe risk factors related to said problem. This research aimed 
to explore the dynamics of why persons with Bipolar Mood Disorder default their medication 
and the sample population was selected using specific inclusion and exclusion criteria, 
making an exploratory, cross-sectional research an appropriate fit. Exploratory research is 
more open, flexible and inductive due to the fact that the methodology aims to look for new 








3.2.1. A Qualitative Approach 
 
Qualitative research is centred in peoples lived experiences, beliefs, values and meaning 
systems from their own perspective (Mason, 2002). This approach to research is considered 
to be more subjective and it considers the social context of people. The aim of qualitative 
research is to increase insight and understanding of phenomena in order to answer the 
research question. The aim of this study was to identify the dynamics hindering adherence to 
medication amongst both male and female Bipolar Disorder clients. This was done with the 
ultimate goal of recognising the particular dynamics experienced by the study population 
resulting in poor adherence to their medication as well as to identify strategies that can be 
implemented to address non-adherence to medication for the treatment of Bipolar Disorder. 
Specific attention was paid to participants’ episodes of being unwell and how these impact on 
their adherence, their experience of medication ineffectiveness and/or side-effects as well as 
their knowledge and insight regarding their condition and whether they recognise the value 
and importance of medication to their wellness.  
 
Qualitative research requires entails systematic collection and interpretation of material given 
by participants which in this research was acquired from a semi-structured face-to-face 
interview. The advantage of using this type of research methodology was that the researcher 
could acquire rich and complex data which may have been lost had a quantitative study been 
conducted (Mason, 2002).  
 
 
3.2.2.  Data Collection Instrument – Semi-Structured Interviews 
 
As an instrument for data collection this study utilised semi-structured interviews. Interviews 
were guided by an interview schedule with open-ended questions and probes. Semi-structured 
interviews consist of a number of key questions that help to define the areas to be 
investigated in the study, but also allow the interviewer and interviewee to explore ideas in 
great detail (Neuman, 2011). According to Neuman (2011), a semi-structured interview 
comprises of a standardized series of questions that because of their flexibly, allow for the 
researcher to ask follow up questions based on the response given. Core themes that were 
addressed in the semi-structured interview were developed on the basis of a review of 





Cuerrier, 1992, and Rhodes and Courneya, 2003) and consultation with identified national 
experts in the fields of research methodology and Bipolar Disorder.  
 
The interviews were conducted face-to-face between the researcher and the participant. 
According to Opdenakker (2006), face-to-face interviewing is a beneficial data collection 
technique in that it allows for a greater amount and more complex information to be 
collected. Furthermore, participants are more likely to allow more time to be spent during a 
face-to-face interview than a telephonic interview or online survey. Furthermore, 
questionnaires and online surveys run the risk of individuals not personally completing the 
questions themselves but rather having someone else fill them out for you whereas face-to-
face interviews remove this risk. Another advantage of face-to-face interviews is that 
individuals who struggle to read and write are not excluded from the research as the interview 
is verbal rather than written. Most importantly, according to Opdenakker (2006), face-to-face 
interviews often give the most quality data due to the fact that the researcher has control over 
the data collection process. There is also a higher response rate for face-to-face interviews in 





The sampling procedure used in this study was non-probability sampling. According to Terre 
Blanche, Durrheim, and Painter (2006), non-probability sampling refers to non-random 
participant selection. Purposive sampling was the sampling strategy used in this research, 
which entails not including just anyone in the research study based on their availability, but 
rather participants are chosen based on specific inclusion and exclusion criteria. In the case of 
this research, only individuals over the age of 18 years with a formal diagnosis of Bipolar 
Mood Disorder were included in the research. Furthermore, participants had to have been 
non-adherent to their medication within a one-month period and must be deemed to be 
clinically stable by their private psychiatrist whom was the gatekeeper for this research.  
 
The rationale for using purposive sampling was that the sample population is a vulnerable 
group, in that they have a diagnosed mental illness, and as such it was important that the 
participants be deemed clinically stable in order to ensure that no mental harm would result 





vulnerable group of participants is that it is often difficult for patients with Bipolar Mood 
Disorder to recognise the phase of their illness as judgement and impulsivity is known to shift 
during different phases of their illness (hypomania, mania and depressed phases). As such 
when acquiring a study sample, the researcher made a decision to acquire clinically stable 
patients to collect data from so as to minimise this effect during data collection. 
 
Participants were recruited via a private psychiatrist whom works in Durban South, whom 
was the gatekeeper for this research. All participants were selected based on whether they 
were determined to be clinically stable as assessed by the psychiatrist as well as whether they 
met the research’s inclusion and exclusion criteria. These will be discussed in more detail 
later in this section.  
 
The psychiatrist supplied the researcher with a list of eligible participants to be contacted. 
Each eligible participant was contacted and given a description of the research to be 
conducted and asked for their participation. Upon verbal agreement to participate in the 
research, each participant was met by the researcher in a place determined to be convenient 
for the participant. The sample size originally desired by the researcher was 10 participants, 
however, due to time constraints and the qualitative nature of this research, the sample size 
was 6 participants. According to Terre Blanche et al. (2006), a sample size of 6-8 sources is 





The data collection instrument as previously mentioned was a semi-structured face-to-face 
interview (see attached research interview in Appendix 1). The researcher did not anticipate 
that any participant would be at risk of mental or physical harm and the researcher refrained 
from asking personal or distressing questions. The interview was also conducted in a place of 
choice and convenience for the participants in order to allow for them to choose a place that 
was comfortable for them to speak in an open manner. The interviews took approximately 25 
minutes to complete and thus did not inconvenience the participants during their day and 
questions were kept simple with neutral language and no jargon. Participants were required to 





their names and finally answer the closed ended and open ended questions asked of them by 
the researcher.  
 
Informed Consent:  
The first part of the interview involved participants signing an informed consent form (see 
attached in Appendix 2). These consent forms were available in both English and isiZulu. The 
participants of the study were required to meet certain inclusion criteria. These included:  
 
 Patients who have been non-adherent to part or all of their treatment regimen 
(involving both follow-up consultations and medication use)  
 Adult patients (both male and female)  
 Bipolar Mood Disorder patients 
 Able to speak English or isiZulu  
 All participants that have been determined to be clinically stable as assessed 
by the psychiatrist   
 
Persons deemed unsuitable for participation in this study included:  
 Children and minors  
 Non-Bipolar Disorder patients  
 All patients deemed unsuitable for participation by the psychiatrist 
 
Bio-demographics:  
Participants were required to answer demographic questions including their age, gender, race, 
highest level of education, employment status, marital status as well as the age of their formal 
diagnosis of Bipolar Mood Disorder.  
 
Interview Schedule:  
The semi-structured interview consisted of 11 questions in total. The first question was a 
screening question in order to ascertain if a participant met all the inclusion criteria, most 
importantly a history of non-adherence to their Bipolar Mood Disorder medication within the 
last month. The questions thereafter were divided based on themes recognised in relevant 






1. Perceived Barriers (Side effects, socio-economic factors etc.) 
2. Beliefs and Attitude toward the Behaviour 
3. Self-Efficacy and Cues to Action 
 
 
3.5.Data Collection and Procedures 
 
Once the researcher was given a list of eligible participants by the private psychiatrist, each 
participant was contacted telephonically and the researcher introduced themselves and the 
nature and purpose of the study as well as the fact that interviews would be audio-recorded 
for research purposes. Thereafter the participant was asked if they wished to participate in the 
study which was strictly voluntary. Once verbal consent was received, the researcher asked 
the participant on which date, time and place would be of most convenience for them in order 
to meet for a face-face interview. When the participant was met face-to-face, they were re-
introduced about the nature and aim of the study using the information sheet (see attached 
Appendix 3). Confidentiality was assured to each participant. The participant would then be 
given an informed consent form to read and sign. Each interview was audio-recorded using 




This study was approved by the Humanities and Social Sciences Research Ethics Committee 
(protocol ref no: HSS/1541/016M) (see Appendix 4). Care was taken to provide adequate 
information about the study and consent was obtained before the interviews were conducted. 
The supervisor of this study is a registered Clinical Psychologist whose contact details were 
made available to patients, should they experience any form of distress as a result of the 
study. Consultations were made available free of charge. If it was deemed that the 
participants experienced psychological distress that required psychiatric intervention, the 
treating psychiatrist would be contacted with an appropriate referral. 
The consent form and information form given to each participants contained the aims and 
objectives of the study and clarification that this research is a compulsory part of the 
research’s Master of Social Science in Clinical Psychology degree. Participants were 





participants were not required to release their names. Data and audio-recordings were 
securely stored in an online version which was only accessible to the researcher. Electronic 
data is to be kept for five years in the Discipline of Psychology. Participants were provided 
with contact details of the researcher, research supervisor and an administrator of the 
Humanities and Social Sciences Ethics Committee of the University of KwaZulu-Natal 




Data were analysed using thematic analysis. Each participant audio-recording was transcribed 
verbatim by the researcher and analysed thematically in order to identify commonalities and 
variances among the responses of participants. Comparative analyses were made across the 
variable gender.  
According to Boyatzis (1998), thematic analysis is a way of seeing, by making observations 
and coming to the insights “intuitively”. People use thematic analysis to see something that 
had not been evident to others, and this is done by perceiving a pattern, or theme, in 
seemingly random information. The perception of this pattern allows one to proceed to the 
next step, which involves classifying or encoding the pattern by giving it a label or definition 
or description. Thereafter, the third major step involves interpreting pattern. As a process of 
encoding qualitative information, thematic analysis facilitates the location of themes found in 
information that at a minimum describes and organizes the possible observations and at 
maximum interprets aspects of the phenomenon. A theme may be identified at the manifest 
level (directly observable in the information) or at the latent level (underlying the 
phenomenon).  
By using a data driven approach, which is constructed inductively from raw information, 
information appreciation is enhanced and with a complete view of the information available, 
the researcher can appreciate gross (i.e. easily evident) and intricate (i.e. difficult to discern) 
aspects of the information (Boyatzis, 1998). However, the approach of developing a code on 
the basis of prior research places the researcher approximately in the middle of the 
continuum. The theory driven approach is one of the more highly popular approaches, and in 
this approach the researcher begins with the theory of what occurs and then formulates the 





emerges from the theorists’ construction of the meaning and style of communication or 
expression of the theory.  
Combining this approach with the prior data driven approach, provided the researcher with a 
broader knowledge base when developing themes that were investigated, and such 
preliminary investigations of existing phenomena increases inter-rater reliability (Boyatzis, 
1998). 
 
3.8.Reflection on Challenges 
 
The data collection process proved to be difficult due to the need to rely on a gatekeeper for 
participants. This resulted in time spent waiting for a list of suitable participants which 
impinged the research from being continued until such a time as participants were identified. 
Furthermore, the process of needing to meet the participants face-to-face also proved to have 
some difficulties as participants would sometimes cancel and reschedule a meeting date and 
this too resulted in data collection being a slow process.  
In relation to data analysis, the use of a semi-structured interview proved most useful as the 
researcher was able to gain data with depth and richness. This was due to the use of probing 
and the ability to ask participants further questions which helped acquire more detail from 
each participant.  
 
3.9.Credibility, Transferability, Dependability and Confirmability  
 
In order to ensure the trustworthiness of this research, the following aspects were targeted:  
 
Credibility (Internal validity):  
According to Trochim (2006), credibility involves establishing that the results of qualitative 
research are believable from the perspective of the research participants. Qualitative research 
attempts to understand phenomena from the eyes of the participants, and as such only 
participants can judge the credibility of the results. Credibility in this research was ensured by 






 No information obtained from each participant was altered or amended nor was any 
information created.  
 The data was audio-recorded and transcribed verbatim so as to capture the exact 
thoughts and feelings of the participants.  
 Thematic analysis was used in order to find themes in the content among each of the 
participants interviews.  
 Ensuring honesty by allowing participants the right to voluntarily be part of the 
research and the ability to withdraw their participation at any point during the 
interview.  
 
Transferability (External Validity):  
Transferability refers to the degree to which research results can be generalised or transferred 
to other contexts or settings (Neuman, 2011). This studies transferability was affected by its 
few participants (6 in total). Furthermore, focus on only individuals treated for Bipolar Mood 
Disorder in the private sector may affect the results transferability to those being treated in 
the public sector. Another transferability difficulty with this research is that this research 
focuses specifically on medication non-adherence amongst people diagnosed with Bipolar 
Mood Disorder and as such the results may not be generalised to all types of mental illness.  
 
Dependability (Reliability):  
According to Trochim (2006), dependability refers to the ability of research to be replicated 
or repeated. In essence, dependability is concerned with whether the study would achieve the 
same or similar results should it be repeated. In order to increase the dependability of this 
research, certain steps were taken:  
 The research process undertaken by the researcher was explicitly explained in the 
methodology section.  
 Both the advantages and disadvantages of the research methods were included.  
 A copy of the research instrument was attached and details of the data gathering 
process were provided.  
 
Confirmability (Objectivity):  
Qualitative research is subjective and each researcher brings forth their own perspective to 





corroborated by others (Trochim, 2006). Steps to enhance confirmability of this research 
were undertaken including methods for:  
 
 Reduction of bias:  
The very best information was attempted to be obtained from each participant through the use 
of both open and closed ended questioning, thus allowing for the participants to elaborate on 
what they want to share through the use of both open and closed ended questioning, thus 
allowing for the participants to elaborate on what they wish to share with the researcher. The 
questions in the interview were concise and clear to prevent any confusion, ambiguity or 
misunderstandings. Clear instructions were provided to ensure that participants fully 
understood what was required of them. Furthermore, the interview was conducted on a 
personal level thus participants were able to inform the researcher if they required 
clarification. Overlapping questions were avoided and only relevant questions pertinent to the 
study were asked.  
 
3.10. Summary of Chapter  
 
To summarise, this chapter entailed the procedures used to answer the research question. It 
began with details on how the research was designed and the reasons for these decisions. A 
short section on the sampling procedures i.e. convenience sampling was presented. The 
qualitative semi-structured research instrument was discussed in more detail. The thematic 
analyses process was discussed and the themes that were found were mentioned, which will 
be discussed in more detail in the next chapter. Reflections on what the researcher found 
challenging about the research process were also discussed. This section concluded with steps 
the researcher took to increase the validity and rigour of the study. In the next chapter, i.e. 
chapter four, the findings of the study will be presented and discussed in detail with 













DISCUSSION OF RESULTS 
 
 
4.1. Introduction  
This chapter reports on the biographical information of the research participants and the 
findings of this study which are derived from the analysis. This chapter will also explore the 
different core themes linked to the objectives of the study such as perceived barriers (Side 
effects, socio-economic factors etc.), beliefs and attitudes toward the behaviour as well as 
self-efficacy and cues to action.  
 
4.2. Demographic details of participants 
The total number of participants in this research was 6, with an equal number of males and 
females (three males and three females) (see table 4.2.1). The ages of the participants ranged 
from the youngest being 28 years, and the oldest being 59 years. These two figures were the 
outlying ages, with the majority of the participants within the age bracket of 40 years and 50 

































Medication History of 
Non-
Adherence 
1 46 Male 31 Private I Epilem, Epitec, 
Dopaquel 
Yes 




3 59 Female 39 Private II Camcolit Yes 




5 52 Female 49 Private I Cymgen, 
Camcolit 
Yes 







4.2.1. Initial Diagnosis  
In this study, the mean age of diagnosis amongst all of the participants was 32,33 years. 
Within this research, all of the participants (100%) sought psychiatric intervention initially 
for their depressive symptoms only, with participants 3, 5 and 6 initially receiving a diagnosis 
of Unipolar depression:  
Participant 3 (female): “My first diagnosis was just plain, straight depression.”   
As a result of an initial diagnosis of Unipolar depression, participants 3, 5 and 6 were all 
originally initiated on antidepressant medications, with participant 3 being placed on 
Surmontil, participant 5 on Prozac and participant 6 on Nuzak.  
 
4.2.2. Specialist VS Non-Specialist Health Care Providers   
All of the participants (100%) were diagnosed with Bipolar Mood Disorder in the private 
sector. Five of the participants in this research (83,33%) were diagnosed by registered private 
psychiatrists, however, participant 6 stated that she was first diagnosed by a private general 
practitioner:  
Participant 6 (female): “It was by a General Practitioner… she informed me that I was 
Bipolar II.”  
The next theme will focus on the different barriers to medication adherence which emerged 
from the data analysis process. Some of the perceived barriers experienced by the participants 
in this research which impact on their medication adherence and self-management were 
found to include medication side effects, cost and availability of medication, private medical 
schemes rules and exclusions, the impact of complex treatment regimens on adherence, as 










4.3.1. Medication Non-Adherence - External Factors 
4.3.1.1. Medication Side-Effects  
Four of the six participants in this research (66,6%) raised concerns regarding the severity of 
the side-effects of their medication and stated that the negative side-effects contributed not 
only to what they perceive as poor quality of life, but also such side-effects resulted in each 
participant being non-adherent to their medication in at least one point of their treatment.  
Negative side-effects from the medication were expressed by 4 of the participants in the 
following way:  
Participant 3 (female): “What I found in my second year teaching at school when I 
was signing reports, my whole hand shook from taking the tablets. I couldn’t sign my 
name… I also get a very dry mouth.”  
Participant 5 also stated that she experiences shakiness throughout her body as a side-effect 
of her medication:  
Participant 5 (female): “I get terrible shaking which happens every single time I wake 
up from sleeping, my whole body shakes.”  
Other common side-effects mentioned by the participants of this research included weight 
gain and a sense of not feeling like “themselves” on the medication:   
Participant 2 (male): “I have about a half-hour gap after taking them (the medication) 
and then I feel numb.”  
Participant 5 (female): “One of the side-effects of the one tablet I am on is nausea and 
sometimes vomiting, which I don’t like very much. This is one reason that would 
cause me to decrease my dosage and eventually not take it… I also don’t like the way 
that you feel on them, like you don’t have much of a personality… I experienced 
weight gain and it did concern me in the past but not now.”  
Participant 6 (female): “Before coming off my medication I started feeling as though I 







4.3.1.2.  Cost and Availability of Medication  
Another barrier to adherence of medication amongst the participants of this study included 
the cost and availability of their treatment. In this study half of the participants (50%) 
experienced difficulties in terms of the availability of their medication. For participant 1, 
acquiring his medication from his local pharmacy was difficult and this would sometimes 
result in him missing his treatment for up to 5 days:  
Participant 1 (male): “There’s been endless fighting. A lot of the time I would go to 
Clicks and they would end up only giving me half of the medication and say they 
needed to order the rest. Then there are problems with the medical aid as they monitor 
how much medication I have per month. I mainly have a problem with getting my 
Epilem.”  
 
4.3.1.3. Private Medical Schemes Rules and Exclusions 
Coinciding with the quote above by participant 1, difficulties with medical aid paying for 
prescribed psychiatric medication was also experienced by participant 5 who stopped taking a 
prescribed medication without discussing it with her psychiatrist due to medical aid not 
covering the particular quantity of tablets she was meant to be taking per month:  
Participant 5 (female): “I stopped taking the Abilify because the medical aid would 
not cover the quantity of tablets I was supposed to be on. It only paid for me to have a 
quarter of the dosage, which I didn’t feel was very practical, since I was supposed to 
be on three times that amount so I stopped taking it all together.”  
Participant 2 also stated that they had limited medical aid which resulted in having to pay a 
monthly excess which he described as “exorbitant”. This highlights the high costs of some of 









4.3.1.4. Impact of Complex Treatment Regimens on Adherence  
Half of the participants in this research (50%) stated that they sometimes forget to take their 
medication daily:  
Participant 1 (male): “Sometimes when I am in a rush or have overslept then I may 
miss my dose.”   
Participant 2 (male): “Either I just forget or I am too tired to take them.”  
Participant 4 (male): “I sometimes skip a dose on days where I have slept through the 
day.”  
Significantly, each of these three participants reason for forgetting to take their medication 
involved the vegetative function sleep, to which all mentioned being too tired or 
oversleeping. These quotes by these participants may indicate they perceive themselves as 
‘forgetful’ when attempting to adhere to their medication, when in all likelihood, some of the 
sedating effects of their evening doses may impact on their vegetative functioning (e.g. 
hypersomnia) which would subsequently impact on patient’s ability to adhere to their 
morning doses of their treatment. 
Participant 5 stated that she feels her memory has become somewhat worse since the onset of 
her diagnosis: 
Participant 5 (female): “I am definitely more forgetful, I don’t know if that’s normal 
or if it’s another side effect to the medication, but I sometimes struggle to remember 
important things like taking my medicine.”  
 
4.3.1.5. Perceptions of Alcohol and Substance Use in Relation to Course of Illness 
In this research 4 out of the 6 participants (66,67%) admitted to abusing substances at some 
point after they were diagnosed with Bipolar Mood Disorder, and 1 participant in this 
research was still actively using substances:  
Participant 2 (male): “To be honest, I smoke a lot of weed so that helps my mood… I 






Participant 6 stated that during a hypomanic episode she began to use more of her 
antidepressants than was initially prescribed which resulted in her having to attend drug 
rehabilitation in order to be weaned off the medication.  
One participant stated that he was using alcohol as a means to self-medicate his lack of 
sleeping:  
Participant 1 (male): “I went off my meds I think mainly because of stupidity because 
I was drinking a lot… I got false ideas about sleeping better with alcohol use.”  
This statement by participant 1 may point toward the fact that excessive alcohol use played a 
role in him going off his medication. 
Participant 4 also stated that he was drinking alcohol heavily during a depressive episode of 
his mental illness.  
Participant 2 in this research stated that he uses marijuana to self-medicate some of the 
negative mood symptoms of Bipolar Mood Disorder as well as to help with certain side-
effects of his medications such as an increased appetite.  
 
The next section will focus on the different individual and social beliefs and attitudes of the 
participants in this research that impact on medication adherence which emerged from the 
data analysis process. This included societal and social pressure, phases of wellness, 
psychoeducation from mental health care practitioners as well as nature and complexity of 
treatment regimen.  
 
4.3.2. Societal and Social Pressure 
Participant 4 elicited responses that highlighted perceptions regarding the influence of social 
stigma in relation to mental illness. The outcome of such influences appear to generate 
increased feelings of anxiety and low mood which reinforces the social stigma of belonging 
to an ‘outgroup’ in society. Adding to this feeling of being ostracised by society, participant 4 
also had the ‘burden’ of a lack of societal acceptance of his sexual orientation to manage:  
Participant 4 (male): “There is a big stigma attached to being mentally ill but also to 





Participant 6 stated that she was influenced to stop her medication by a friend:  
Participant 6 (female): “A friend of mine came to visit from the UK and told me she 
had just stopped her antidepressants. I also wanted to see if I would be ok without my 
medications.”  
Participant 1 experienced social pressure from family and friends to both stop his medication 
and even use substances:  
Participant 1 (male): “There are plenty of people who think they are psychiatrists… 
there are some people who tell you to stop taking the medication, yet are the same 
people who tell you to start taking it again when things go wrong… You start thinking 
if maybe they are right and you don’t need the medication… some of my family and 
friends even suggested I start smoking cannabis which I will never do.”  
This quote from participant 1 may indicate societal perceptions of mental illness, with an 
indication of their misunderstandings regarding mental illness being exacerbated by the 
variation in their symptoms. Such misperceptions can lead to patients being encouraged 
towards recreational substance use as a socially desirable method of coping. 
According to participant 2 in this research, he stated that he mostly adheres to his medication 
for his family’s sake as he knows he causes them stress and harm when he is either manic or 
depressed:  
Participant 2 (male): “It’s not for me, it’s for everyone else!”  
Participant 2 in this research appears to perceive adherence in relation to an external locus of 
control, i.e. families need for harmony as a motivating factor. It may also indicate the poor 
level of insight a patient has when experiencing different states of the illness. 
Bipolar Mood Disorder can have severe impacts on the family and other loved ones of the 
affected person such as having to look after and monitor the affected person who may be 
engaging in risky behaviour during phases of being unwell which can disrupt normal routine, 
but also relationships can take strain during episodes of being unwell, and finances can be 








4.3.3. Phases of Illness  
Participant 5 in this research reported that during both phases of being unwell and well, she 
struggled to see the importance of taking her medication which resulted in poor adherence to 
her treatment regimen: 
Participant 5 (female): “Sometimes I feel it (the medication) is unnecessary and that 
my dose is too high… when you have been fine for so many years you don’t know if 
it is the medication that is making you feel fine or if you are fine, and if the 
medication is actually necessary.”  
This quote from participant 5 speaks to the difficulty experienced by patients who suffer from 
Bipolar Mood Disorder in relation to how the illness unfolds both at a biochemical level and 
at a functional level. The uniqueness of the patient’s presentation makes it hard for them to 
understand how the different medications used in combination help to ensure mood stability 
rather than eliminating all of their symptoms of mental illness in their entirety.  
Participant 2 stated that when he is either in a manic or depressive episode he begins to stop 
seeing the importance of taking his medication as compared to when he is well in which he 
views medication as being a necessary part of his treatment. This coincided with participant 5 
who stated that when she is unwell she feels that her views on the importance of her 
medication changes as she feels she loses control over what she does or thinks. Participant 1, 
3, 4 and 6 in this research all stated that they perceive their medication as necessary 
regardless of whether they are well or unwell and that during episodes of being unwell, it is 
usually the adverse symptoms that encourage them to take their medication.  
 
4.3.4. Psychoeducation from Mental Health Practitioners  
In this research 2 of the participants (33,3%) stated that they received no psychoeducation 
from their mental health care practitioner regarding their diagnosis and the medications they 
are taking:  
Participant 1 (male): “The psychiatrists didn’t seem to explain anything to me about it 
(Bipolar). They ask questions about how many ‘highs and lows’ you have and give 
medication. I understand what the medication does and how it alters the body and the 
brain, but only to the point that I can understand based on my own research… I think 





are the ones that should be informing you. I still think that psychiatrists could explain 
to you in a simpler way though.”  
Participant 5 (female): “It might be nice to have your diagnosis explained to you, not 
in a long story but explaining aspects of how you should live with it.”  
This lack of psychoeducation from mental health care providers may impact on the 
perception of the necessity of taking one’s medication, in which a lack of information may 
lead to the belief that medication is unnecessary and more of a burden to one’s quality of life. 
Furthermore, a lack of psychoeducation from one’s mental health care practitioner can 
interfere with rapport, which may result in patients not trusting their mental health care 
providers and also result in poor health seeking behaviour should they feel their medication is 
not working for them.   
 
4.3.5. Nature and Complexity of Treatment Regimen   
In this research, only 1 participant (Participant 3) was taking just one tablet, with all the other 
participants taking at least three different medications as part of their treatment regimen. 
Participant 2 was not only taking medication for Bipolar but also for a comorbid medical 
condition, diabetes mellitus. Only 2 of the participants had a once a day dose of medication 
whereas 4 of the participants (66,67%) had a twice daily dosage, having to take different 
medications in the morning and night.  
Participant 2 who is on 8 different medications, both for the treatment of his Bipolar Mood 
Disorder and diabetes mellitus stated that although he was not sure if his medications were 
meant to be split into two daily doses, he chooses to take all of them at night before sleeping 
in order to reduce his chances of forgetting to take his medications.  
Amongst the participants in this research, 5 of the participants (83,3%) stated that the method 
which they use to remember to take their medication is by trying to incorporate it into a daily 
activity which they carry out every day. Participant 5 stated that she uses an alarm on her cell 
phone to help remind her of when she needs to take her medication. Participant 4 and 6 stated 
that in the past they used a weekly pill box in order to keep track of their medications but 
have since incorporated their medication taking into their daily routine. Although he mostly 
remembers to take his medication on his own, participant 1 stated that his wife also helps by 





4.4.1. Self-Learning Research  
In this research, all of the participants (100%) did their own form of research regarding either 
their diagnosis of Bipolar Mood Disorder or their medication and the side-effects they may 
have. All of the participants stated that they mainly researched their medication and the side-
effects that may cause, possibly indicating that for these participants the side-effects of their 
medications were of more concern. Three of the participants (50%) stated that doing their 
own research was helpful to them:  
Participant 1 (male): “It doesn’t really worry me now that my psychiatrist didn’t 
explain things to me as I do the research myself. It was a problem when I was younger 
because I would wonder what medication I was being given and why, and if it was 
really necessary. Now I just use Google.” 
Participant 3 (female): “I have done a lot of Googling on it (Bipolar) and it helped me. 
It calmed me down.”  
Participant 5 found doing her own research helpful as it gave her insight into the side-effects 
of her medication and therefore a possible reason for her symptoms of nausea:  
Participant 5 (female): “I tried to find out what was causing the nausea. After I did my 
research I felt better; it was nice to know what was causing it.”  
The participants in this research all showed self-efficacy in relation to their mental illness as 
they all attempted to educate themselves about their mental illness and the medications they 
are having to take every day.  
 
4.5. Summary of Chapter  
This chapter included all the findings of this research and the interpretations of the data 
collected from each of the 6 participants. Responses from the data set were used to illustrate 
the experience of the participants in relation to specific content areas. In the next chapter of 
this study, an interpretation of the results of this research will be conceptualized in relation to 
the Theory of Reasoned Action and the Theory of Planned Behaviour with the findings also 













This chapter will explore the different core themes linked to the objectives of the study in 
relation to three constructs identified from the Theory of Reasoned Action and the Theory of 
Planned Behaviour namely perceived barriers (side effects, socio-economic factors etc.), 
beliefs and attitudes toward the behaviour as well as self-efficacy and cues to action. 
Furthermore, the results of this research will be interpreted in relation to relevant existing 
literature in order to compare the findings of this study with previous studies. 
 
5.2. The Theory of Reasoned Action and the Theory of Planned Behaviour in 
Relation to Medication Non-Adherence 
 
According to a study conducted by Ben-Natan et al., (2013), many factors related to the 
Theory of Reasoned Action and Theory of Planned Behaviour contributed to their 
participants’ adherence to medication. These included their state of health, the dosing 
frequency of their medication, their behavioural beliefs and attitude towards the medication 
and its usefulness to their wellness as well as its consequences such as side effects, their 
behavioural intention and whether or not they chose to take their medication, the normative 
beliefs in the form of social pressure to take their medication and finally, their subjective 
norms and perception of the beliefs of people they hold close to them.  
As such, it is evident that many factors play a role in the level of adherence to medication and 
adherence appears to be influenced by both individual beliefs and perceptions as well as the 
perception of the beliefs of others. The research findings of Ben-Natan et al., (2013) found a 
correlation between behavioural attitudes and beliefs regarding adherence to medications as 





described by Ben-Natan et al., (2013) were found to influence medication adherence amongst 
the participants in this research and these factors shall be explored in more detail within this 
chapter.  
 
5.3. Non-Dynamic Factors  
5.3.1.  Challenges in relation to Formal Diagnosis 
According to the Diagnostic and Statistical Manual of Mental Disorders 5th edition, the mean 
age of onset of Bipolar Mood Disorder is 18 years old (American Psychiatric Association, 
2013). However, in this study, the mean age of diagnosis was 32,33 years. This late diagnosis 
of Bipolar Mood Disorder amongst the participants in this study may be due to factors such 
as an individual not perceiving themselves to be unwell during manic states and resisting the 
need for treatment (Singh and Rajput, 2006). This may indicate the perceptions patients have 
regarding their mental illness in that symptoms of depression have been understood 
differently to symptoms of Bipolar Mood Disorder. The significance regarding their 
understanding emphasises the impact of knowledge about one’s state and the journey they 
take when accessing mental health care, in relation to gaining insights into the nature and 
extent of their illness.  
Within this research it was found that some participants first received a diagnosis of unipolar 
depression. Singh and Rajput (2006) state that almost 40% of Bipolar patients are initially 
diagnosed with depression. According to Singh and Rajput (2006), Bipolar Mood Disorder is 
often misdiagnosed, with 69% of patients initially misdiagnosed and a further 10% remaining 
misdiagnosed for up to 10 years. Singh and Rajput (2006) found that misdiagnosis does occur 
amongst patients with Bipolar due to most of these patients only seeking treatment for 
depressive symptoms. The misdiagnosis of Bipolar Disorder can have treatment 
complications in which often only an antidepressant is given which can even trigger manic or 
hypomanic episodes. 
 
5.3.2. Specialist VS Non-Specialist Health Care Providers     
Within this research, one participant was initially diagnosed by a general practitioner. 
According to a study conducted by Afana, Dalgard, Bjertness and Grunfeld (2002), general 





health care and that only 11,6% of patients with a mental disorder were able to be detected by 
general practitioners. This shows a need for general practitioners to be better trained 
regarding mental illness detection but also a need for mental illness diagnoses to be properly 
assessed and made by a psychiatric specialist. According to Singh and Rajput (2006), 
psychologists and psychiatrists are properly trained to treat mental illness and use specially 
designed assessments and interviews to evaluate and diagnose a person with a mental illness. 
As such, it is out of the scope of practice for a general practitioner to diagnose and treat 
mental illnesses such as Bipolar Mood Disorder as there lies a risk for misdiagnosis or for a 
mental illness to be unrecognised.  
 
5.4. Dynamic Factors 
The findings of this study confirmed that patient attitude has a major influence on human 
behaviour and how the engagement in certain behaviour by a person was motivated by two 
major factors, namely their attitude toward the behaviour as well as a social component, 
known as subjective norms, which is what other people believe he or she should do. This is 
the major principles of the Theory of Reasoned Action and the Theory of Planned Behaviour, 
which was found to guide the behaviour of the participants in this research. The emerging 
themes include perceived barriers, behavioural belief and attitude toward taking medication 
as well as self-efficacy and cues to action.  
 
5.4.1. Perceived Barriers  
In a study conducted by Blixen, Kanuch and Sajatovic (2016), some of the perceived barriers 
found to impact on medication adherence and self-management amongst their participants 
included medication side effects, financial difficulty and availability of medication, phases of 
illness and wellness as well as substance and alcohol use. These barriers implicating 
medication adherence were further confirmed in this research.  
 
5.4.1.1 Medication Side-Effects  
According to the Theory of Reasoned Action and the Theory of Planned Behaviour, people 





pro’s or con’s for engaging in particular behaviours (Hausenblas, Carron and Mack, 1997). If 
the individual perceives there to be more negative consequences of a certain behaviour, then 
they are less likely to engage in such a behaviour. In a study conducted in Turkey by Mert, 
Turgut and Semiz (2015), Bipolar Mood Disorder was found to have the highest rate of 
medication non-adherence, with negative side-effects from medications resulting in 26,8% of 
the participants failing to adhere properly to their treatment regimen. Within this research, 
66,6% of the participants experienced negative side-effects from their medications for 
Bipolar Mood Disorder which resulted in each of these participants being non-adherent to 
their medication in at least one point of their treatment as they perceived the negative side-
effects of the medication to outweigh the benefits of being on their medication. 
Kemp (2014) highlights certain common side-effects of Bipolar medications including weight 
gain and Parkinsonian features like shaking, much like those expressed by the participants in 
this study. Furthermore, Kemp (2014) states that certain medications used in the treatment of 
Bipolar result in sedation of the patient, which is meant to help with sleep but can also affect 
a persons’ quality of life by contributing to weight gain and cognitive dysfunction as well as 
impair their social and occupational functioning. These symptoms were further confirmed in 
this research by four of the six participants.  
Kaplan, McGlinchey, Soehner, Gershon, Talbot, Eidelman, Gruber and Harvey (2015) state 
that hypersomnia and elevated sleepiness throughout the day is most common in Bipolar 
Mood Disorder. An increase in sleep has been found to be a medication side effect in up to 
37% of Bipolar Mood Disorder patients, with antipsychotic medication in particular having 
strong sedative properties. Furthermore, excessive sleeping is also a symptom of the 
depressive phase of Bipolar Mood Disorder (American Psychiatric Association, 2013). In a 
study conducted in the United States of America by Kaplan et al. (2015), it was found that 
excessive sleepiness amongst Bipolar Mood Disorder patients can be a predictor of relapse 
into a manic or hypomanic episode as well. In this research hypersomnia was not only found 
to be a side effect of medication and depression, but was also a contributing factor to non-
adherence in which 50% of the participants reported symptoms of hypersomnia that not only 
affected their quality of life but also impaired their ability to take their medication as they 
would sometimes sleep through the entire day or they were too tired to take their medication.  
Memory and cognition have also been found to be impaired during illness phases of Bipolar 





and executive functioning (Marvel and Paradiso, 2004). These factors can also contribute not 
only to forgetting to take ones’ treatment but also change how a person perceives the 
importance of their medication during that particular phase of illness. This was evidenced in 
this research in which one participant stated that during a depressive phase of his illness, he 
stopped taking his medication and instead started self-medicating with alcohol due to 
impairment in his reasoning and executive functioning. Impairment in reasoning and 
executive functioning evidenced by this participant goes against one of the fundamental 
assumptions of the Theory of Reasoned Action and the Theory of Planned Behaviour which 
states that people make choices by use of rationality and sensibility (Hausenblas, Carron and 
Mack, 1997). In cases of cognitive impairment during a phase of mental illness, a person’s 
rationality is often impaired which would therefore interfere with their ability to make 
sensible decisions regarding certain behaviours such as remaining adherent to their treatment 
regimen.  
Furthermore, mood stabilisers such as Lithium, which are the main form of pharmacological 
treatment of Bipolar Mood Disorder, have been found to impair the memory of people with 
Bipolar. This was evidenced in a study by Vasile, Vasiliu, Mangalagiu and Ojog (2011), in 
which the memory performance and productivity of patients with Bipolar Mood Disorder 
were found to improve when their mood stabiliser was discontinued for a period of time. 
Thus the medication in which patients need to remember to take also contribute to the reason 
they forget to take the medication. Impairment in memory and cognition was confirmed in 
this research in which one participant reported being increasingly forgetful since her 
diagnosis of Bipolar Mood Disorder, and three more participants reporting that they 
sometimes forget to take their medication due to excessive sleepiness as a result of the side-
effects of their medication. 
Neuropsychological studies have found that medications such as mood stabilisers like 
Lithium can result in side-effects including emotional inadequacy and even reduce ones’ 
productivity and creativity levels (Vasile et al., 2011). This may be why 50% of the 
respondents in this research state that they often do not “feel like themselves”. As a result of 
not feeling like himself, one participant in this research admitted to abusing marijuana as a 
means to improve his mood. This factor shall be discussed in more detail within the theme of 
alcohol and substance use, however what was apparent was a sense of ‘detachment’ from the 





5.4.1.2. Cost and Availability of Medication  
According to Hassim (2007), despite psychiatric illnesses contributing to 14% of diseases 
worldwide, many medical aid schemes limit psychiatric benefits. This is evidenced in how 
access to certain medications for the treatment of mental illnesses are limited depending on 
which medications are on the “Essential Drug List”. Difficulties with regard to cost and 
availability of medication acts as a barrier to health seeking behaviour in which seeking care 
is delayed and needs are not met when individuals struggle to afford or acquire their 
medications (Institute of Medicine, 2002).  
In this research 50% of the participants experienced difficulties in attaining their medications 
from their medical aid schemes, in which one of these participants stopped taking a 
prescribed mood stabiliser due to her medical aid not covering the cost of this medication. In 
relation to the Theory of Reasoned Action and the Theory of Planned Behaviour, this 
research again disagrees with the notion that decisions to act out certain behaviours are based 
on rational decision-making, in which sometimes even an action which a person perceives to 
be in their best interest is not possible to enact due to external factors which act as barriers to 
their decision-making process.  
Evidenced from this study is that there is a need for better access to mental health 
medications in the private sector in South Africa, however, according to Hassim (2007), there 
are even fewer mental health resources available in the public sector. Not only are there few 
psychiatrists being hired in the public sector, but also many primary health care clinics do not 
treat psychiatric illnesses and there is limited access to clinics that do treat mental illness.  
 
5.4.1.3. Alcohol and Substance Use  
According to Quello, Brady and Sonne (2005), substance use disorders are often comorbid in 
mood disorders such as Bipolar Mood Disorder. Quello, Brady and Sonne (2005) theorise 
that mood disorders can place an individual at risk of developing a substance use disorder and 
vice versa, in which the negative affect associated with a mood disorder may result in an 
individual abusing substance as a means to cope whilst a substance use disorder may foster 
adverse mood symptoms.  
Alcohol and substance use amongst the mentally ill is often perceived by the user as acting as 





psychological distress, however, the opposite is true in which substances such as alcohol 
work as a Central Nervous System depressant which can exacerbate distressing symptoms of 
mental illness (Quello, Brady and Sonne, 2005). Furthermore, substance use also has an 
impact on medication adherence amongst people with Bipolar Mood Disorder as it can impair 
their cognition and executive functioning (Stoner, 2017).  
In this research, 66,6% of participants admitted to using substances as a means to self-
medicate negative mood states such as depression and anxiety as well as a means to improve 
symptoms of insomnia. Furthermore, one participant was even encouraged by family to use 
marijuana as an alternative treatment for their Bipolar Mood Disorder. This highlights one of 
the motivational factors of the Theory of Reasoned Action and the Theory of Planned 
Behaviour, namely the subjective norms of others and how the opinions of those deemed 
important by a person can influence their behaviour (Hausenblas, Carron and Mack, 1997).  
Substances are commonly used by individuals with Bipolar Mood Disorder as a means of 
self-medicating their symptoms, such examples include using marijuana as a means to calm a 
person if they are feeling intense aggression or anger, or stimulant drugs such as cocaine 
being used as a means to energise a person during a depressive episode (Stoner, 2017). 
According to Brady and Sonne (2002), 46,2% of people with Bipolar type I have a comorbid 
alcohol use disorder, whilst the rate of alcohol use disorder amongst people with Bipolar type 
II is 39,2%. The manic and hypomanic episodes of Bipolar Mood Disorder were found to be 
associated with substance use due to mania and hypomania resulting in impulsivity, increased 
risk-taking behaviour and disinhibition (American Psychiatric Association, 2013).  
In a study conducted by Brady and Sonne (2002), it was found that substance and alcohol use 
amongst people with Bipolar Mood Disorder increases their number of hospitalisations and 
may cause the onset of a manic or depressive episode. In this research, one participant was 
actively using marijuana as a means to improve his negative mood symptoms as well as to try 
and curb his appetite which increased as a side effect of his medications and comorbid 
condition, diabetes mellitus. Another participant in this research stated that in his past he 
abused alcohol as he believed that alcohol use would help to improve his sleep, in which 
during a depressive phase he struggled to get a good night’s rest. Furthermore, another 
participant admitted to previously abusing her anti-depressant medications during a 
hypomanic phase due to impaired judgement. Amongst the substance users in this research, 





for the treatment of their mood symptoms as well as to help them overcome their substance 
use disorder.  
 
5.4.2. Beliefs and Attitudes toward the Behaviour  
The Theory of Reasoned Action and the Theory of Planned Behaviour focus on the intentions 
of people which is how motivated they are to perform a particular health promoting 
behaviour such as taking their medication as prescribed (Hausenblas, Carron and Mack, 
1997). Intention is highly motivated by a person’s attitude towards that particular behaviour 
as well as their perception of the social pressure to perform that behaviour. A person’s 
attitude toward a behaviour is also shaped by their perception of the consequences of 
performing a particular behaviour, either positive or negative. In this research the 
participants’ attitudes toward taking their prescribed medication was influenced by the 
following: information received from practitioner, phases of illness, societal expectations and 
complexity of the treatment regimen.  
 
5.4.2.1. Psychoeducation from Mental Health Practitioners  
Psychoeducation involves a mental health practitioner informing and educating a person and 
their family about their particular mental illness in order to help make the patient more aware 
of their condition and to also help the person and their family cope better and reduce the 
chances of relapse (Bond, 2014). Psychoeducation regarding ones’ medication and the 
importance of taking the medication consistently also assists with improving medication 
adherence.  
According to Bond (2014), psychoeducation is an important aspect in the treatment of people 
with Bipolar Mood Disorder and can improve the course of their illness by helping them to 
recognise the signs that they are relapsing which increases health seeking behaviour. 
Psychoeducation helps improve adherence and provide coping mechanisms by educating the 
family of the affected person about Bipolar Mood Disorder which can improve social support 
and reduce stigma within the family unit. Eckenrode (2017), states that medical practitioners 
should be able to speak to their patients in a friendly manner, refraining from using jargon 
that the patient will not understand and listen to the patients concerns and questions. 





a diagnosis to a patient and listen to their questions. In South Africa, there is a shortage of 
mental health care professionals in relation to the country’s population which results in even 
less time for psychiatrists to thoroughly explain a patient’s diagnosis to them (Schneider, 
Docrat, Onah, Tomlinson, Baron, Honikman, Skeen, van der Westhuizen, Breuer, Kagee, 
Sorsdahl and Lund, 2016).  
Two of the participants in this research reportedly received no psychoeducation from their 
mental health care practitioners. A lack of psychoeducation to people with mental illness can 
have implications on their prognosis and adherence to their medication as the person was not 
given proper insight into their condition (Lincoln, Lullmann and Rief, 2007). This can result 
in an individual not understanding the importance of their medication and the need to adhere 
to their treatment regimen. This was seen by one of the participants in this research who 
received no psychoeducation, in which she often questions the necessity of her medication 
and considers whether or not she should stop taking her medication without consulting her 
psychiatrist. Furthermore, a lack of psychoeducation from one’s mental health care 
practitioner can interfere with rapport, which may result in patients not trusting their mental 
health care providers and also result in poor health seeking behaviour should they feel their 
medication is not working for them.  
It was evident in this research that the participants who received no psychoeducation from 
their mental health care practitioner had a poorer opinion not only of the particular mental 
health care practitioner who diagnosed them, but of mental health care practitioners in 
general, in which they perceived mental health care practitioners to be impatient and as 
explaining factors regarding mental illness in a manner too difficult for them to fully 
understand. This may reduce their desire to visit their mental health care practitioner even 
when it is necessary for them to receive help.  
 
5.4.2.2. Phases of Illness  
According to Cavanagh, Van Beck, Muir and Blackwood (2002), there is evidence that 
people with Bipolar Mood Disorder experience cognitive impairment in terms of their verbal 
learning, memory and executive function. Cognitive impairment is seen to occur mostly 
within the affective states of either a manic, hypomanic or depressive episode, however, 





involves managing aspects of oneself by maintaining control and self-regulation (Murray, 
2008).  
Impairment in this cognition and executive functioning during states of being unwell such as 
a manic, hypomanic or depressive phase may result in non-adherence to one’s medication as 
one begins to lack self-maintenance (Murray, 2008). This was evidenced in this research by 
two participants, one who stopped his medication during a depressive phase and the other 
increasing their dose of their anti-depressant during a hypomanic phase. These two 
participants both stated that they were not able to think clearly about their actions during 
these times which impaired their ability to adhere to their medication. As stated previously, 
this is contrary to the assumption of the Theory of Reasoned Action and the Theory of 
Planned Behaviour in which reasoning and sensibility are said to be used to make decisions 
regarding behaviour (Hausenblas, Carron and Mack, 1997). However, during phases of 
illness in Bipolar Mood Disorder, rationality and sensibility are often lost as a result of 
impaired cognition and executive functioning (Cavanagh et al., 2002).  
 
5.4.2.3. Societal and Social Pressure 
People who suffer from mental illness often face stigma and discrimination not just from 
society but also from those close to them such as family and friends (Corrigan, 2004). Stigma 
and discrimination is the result of a lack of education and understanding amongst society 
regarding mental illness and although therapeutic and pharmacological treatments are 
available to the mentally ill, stigma can have a direct impact on the mental wellbeing of 
people with mental illness. Stigma surrounding mental illness can act as a barrier for people 
with mental illness seeking treatment as well as maintaining adherence to their medication 
(Institute of Medicine, 2002).  
In this research, one participant in particular faced social stigma not only regarding his 
mental illness but also regarding his sexual orientation. This participant also reported socially 
isolating himself from others, which may not only be a symptom of depression but may also 
be due to his fear of being confronted with social stigma. The outcome of such influences 
appear to generate increased feelings of anxiety and low mood for this participant which 





According to DiMatteo (2004), poor social support is a risk factor for negative states of 
mental health whilst positive social support is associated with less stress, positive affect states 
and change in behaviours. Social support is also associated with the ability to adjust and 
adapt to a mental illness. Furthermore, a study by DiMatteo (2004) found that the risk of non-
adherence to medication is higher amongst individuals who lack social support or whom have 
negative social support structures. This was evidenced by participant 6 of this research who 
stopped taking her medication because her friend had done the same thing, both without the 
advice of their treating psychiatrists. Another participant also stated to have negative social 
support in which he was encouraged by friends and family to use substances such as 
marijuana as an alternate means to treat his Bipolar Mood Disorder.  
The Mood Disorders Association of British Columbia (2017) states that Bipolar Mood 
Disorder can have severe impacts on the family and other loved ones of the affected person 
such as having to look after and monitor the affected person who may be engaging in risky 
behaviour during phases of being unwell which can disrupt normal routine, but also 
relationships can take strain during episodes of being unwell, and finances can be severely 
impacted due to impulsive behaviour during manic or hypomanic phases or need for 
hospitalisation. This was evidenced by one participant in this research who stated that he 
adheres to his medication as a means to “protect” his loved ones as he understands how his 
mental illness will affect them should he stop taking his medication. He also stated that due to 
not being able to work as a result of his mental illness, his mother has the financial burden of 
having to pay for him to be on medical aid as well as the residual fees for his medication 
which medical aid requires to be paid.  
 
5.4.2.4. Nature and Complexity of Treatment Regimen 
According to Toh et al. (2014), increased amounts of pills and more than one dosage per day, 
as well as medical comorbidities are all factors which may contribute to non-adherence to 
medication. 
Multiple dosages per day as well as many different pills which need to be taken can be 
difficult to keep track of and also hard to remember (Toh et al., 2014). This further links to 
the previous sub-theme on phases of wellness, to which people with Bipolar Mood Disorder 
can experience cognitive impairment both in states of being well and unwell and this too can 





this research, 66,6% of the participants had complex treatment regimens in which multiple 
pills had to be taken multiple times per day. This lead to one participant choosing to take all 
of his medications once a day to reduce his chances of forgetting a dosage despite the 
instructions of his medications stipulating a split dosage.  
 
5.4.3. Self-Efficacy and Cues to Action  
In this research, participants showed self-efficacy toward their mental health by attempting to 
educate themselves about their mental condition and the medications they are on and also by 
finding strategies to ensure that they do not skip any medication doses. However, the 
participants in this research consisted of private mental health care patients, who therefore 
may have had the resources to effectively manage their illness as compared to people from 
the public health care sector. 
Health behaviour such as adhering to one’s medication is influenced by self-efficacy 
(Adefolalu, Nkosi, Olorunju and Masemola, 2014). Medication adherence and self-efficacy is 
also influenced by a person’s beliefs and attitudes about a particular behaviour such as taking 
medication which was previously discussed as a theme in this results section.  As such, self-
efficacy can be defined as “people's beliefs about their capabilities to produce designated 
levels of performance that exercise influence over events that affect their lives” (Bandura, 
1994, pg 2). Self-efficacy influences how a person thinks, feels and essentially behaves and it 
is highly influenced by whether or not a person feels they are able to have control over a 
situation and help themselves.  
 
5.4.3.1. Self-Learning Research  
According to Bandura (1994), having self-efficacy helps to enhance an individual’s feeling of 
accomplishment which allows them to feel capable of facing and overcoming particular 
challenges. In turn, having self-efficacy also enhances the chance of people not giving up 
even if they face a setback and recovering quickly after, such as in the case of a relapse in 
mental health. The participants in this research all showed self-efficacy in relation to their 
mental illness as they all attempted to educate themselves about their mental illness and the 





5.4.3.2. Ways of Remembering to take Medication  
According to Barfod, Sorensen, Nielsen, Rodkjaer and Obel (2006), “I simply forgot” is the 
most common reason that people who are on medication miss a dose. As previously 
mentioned, forgetfulness is made even more common amongst people with Bipolar Mood 
Disorder who can experience cognitive impairment in their memory during both episodes of 
illness and wellness (Cavanagh et al., 2002). Children’s Mercy (n.d) list a few methods which 
can help a person keep track of as well as remind them to take their medications including:  
 
 Taking the medication with an activity which is carried out every day such as 
brushing   your teeth,  
 Set an alarm on a clock or cell phone device,  
 Using a weekly pill box which help compartmentalise your medications,  
 Leaving some extra pills in a bag which you carry every day in case you leave home 
without having taken your medication,  
 Leave your medication with a caregiver or family member should you not manage to 
remember to take the pills on your own,  
 Leave the medication in an easy accessible and visible spot,  
 Placing a reminder note somewhere you will see it every day and, 
 Recording each dose of medication on a calendar so you can be sure that you have 
taken your daily dose (Children’s Mercy, n.d).  
 
Most participants in this research relied solely on their ability to remember to take their 
medication each day through trying to incorporate it into a daily routine activity. One 
participant had social support in the form of his wife reminding him to take his medication 
whilst another set a daily alarm on her cell phone to help her remember her medication. For 
these participants, the act of choosing a particular method to remind them to take their 
medication may have helped participants feel a sense of self-efficacy and control over their 
mental illness, however, the fact that they have a mental illness which sometimes impairs 
their cognition and reasoning results in patients having a loss of control over their actions. 
This was evident in this research in which two participants were non-adherent to their 





people to help them remember to take their medication, these methods prove irrelevant in 
times of mental illness when a person is not able to use reasoning and sensibility.  
 
5.5. Summary of Chapter  
This chapter included an interpretation of the findings of this research in relation to the 
Theory of Reasoned Action and the Theory of Planned Behaviour and a comparison between 
the results of this research and existing research were given. In the next chapter of this study, 
the conclusions of the findings as well as the limitations and suggestions for further research 





























The final chapter of this dissertation will include a short summary, conclusion as well as the 
limitations of this study, followed by some recommendations for future research.  
 
6.2. Study Summary and Conclusions 
The aim of this research was to explore some of the factors that contribute towards poor 
patient adherence to Bipolar Mood Disorder medication treatment regimens. Amongst the 
participants in this research, several themes emerged as factors which act as barriers to non-
adherence to psychotropic medication. These themes were medication side-effects, cost and 
availability of medication, substance and alcohol use, societal and social pressure, 
forgetfulness, phases of wellness, psychoeducation from mental health care practitioners, 
nature and complexity of the treatment regimen as well as self-efficacy behaviours.  
The result of this study provided insights into the lived experiences of patients in treatment 
for Bipolar Mood Disorder. The sample under study (private mental health care patients) 
were considered to be better resourced for care than mental health patients in the public 
health sector. However, challenges still prevailed within multiple domains of managing 
Bipolar Mood Disorder. An example of a gap in the mental health care system described by 
the participants in this research was their difficulties in acquiring their prescribed medications 
through their medical aid schemes. Furthermore, participants described a lack of 
psychoeducation regarding their diagnosis from their mental health care practitioners which 
resulted in poor insight into their mental illness and thus poor adherence.  
A predominant theme that emerged from the study was the experience of medication side-





lack of knowledge gleaned from participants regarding the treatment, course and prognosis of 
Bipolar Mood Disorder. Majority of the participants felt that it was their primary treating 
practitioner’s (psychiatrist) responsibility to inform them of the above.  The resultant effect 
was that majority of the participants justified non-adherence to medication use autonomously, 
as a consequence of negative side-effects rather than the decision being mediated between 
practitioner and patient. The research results demonstrated some form of self-efficacy (self-
learning), whereby participants acquired multiple sources of information from online 
websites that assisted them in understanding the phases on their illness (symptoms) and 
medication side-effects which helped alleviate feelings of anxiety in relation to their 
treatment. 
The nature and complexity of the medication regimen was also identified as a barrier to 
treatment adherence in this research, with majority of the participants taking at least 3 
different pills each day. This contributed towards perceived treatment non-adherence as a 
result of medication being taken not according to what was prescribed from their treating 
practitioner (inappropriate combinations and/or omission of certain doses). From the results, 
it appears that majority of the participants were more comfortable with taking all their 
medication routinely at a specific time of day, rather than using adhering to the prescription. 
Another common theme amongst the participants in this research was the use of substances 
such as alcohol and marijuana. Majority of the participants used substances as a means to 
cope with the negative symptoms of their Bipolar Mood Disorder such as sleeplessness, in 
which alcohol was used to try and bring about sleep. Majority perceived and experienced 
substances/alcohol as having sedating effects. Another area of discussion surrounded the use 
of substances in an attempt to self-medicate the side-effects of some of the medications such 
as by attempting to counter-act the weight gain effect that mood stabilisers have by smoking 
marijuana to curb the appetite.  
The participants in this research expressed how the symptoms of their Bipolar Mood Disorder 
such as hypersomnia often resulted in doses of their medication being missed due to being 
too tired and sleeping throughout the day, resulting in doses of their medication being missed. 
Surprisingly however, majority of the participants in this research stated that regardless of 
whether they are well or unwell, they always recognise the importance and need for their 
medication. In the researchers’ opinion, this insight into the importance of needing their 





specifically their negative symptoms) which may also function as a cue to action (use of 
medication) as an available means to stabilise the illness.  
Social influence was identified as a significant factor towards non-adherence as many 
participants, who valued the opinions of close family and friends, made health behaviour 
decisions (use of narcotic substances) to alleviate symptoms such as insomnia. Social 
judgements of mental illness being a sign of human weakness have been perpetuated by a 
lack of knowledge regarding the nature and treatment of Bipolar Mood Disorder (Crowe, 
Averett, Glass, Dotson-Blake, Grissom, Ficken, Holland and Holmes, 2016).  
 
6.3. Limitations 
The limitations of a study refer to how the particular research design employed by the 
researcher may have influenced the interpretation of the findings. One of the main limitations 
of this study was the sample size in which only 6 participants could be used. Furthermore, all 
of the participants were private mental health care users and as such, no information 
regarding health services in the public sector could be explored. The limitations of this study 
and the effect they may have had on the research results are listed below:  
 
6.3.1. Data Collection Method (face-to-face open-ended interviews) 
According to Szolnoki and Hoffmann (2013), face-to-face interviews have several 
advantages such as a higher response rate and interview flexibility as participants often feel 
more comfortable speaking to a researcher face-to-face than having to fill in answer forms or 
online surveys. However, a major disadvantage of this data collection method is the 
possibility of bias. Furthermore, face-to-face interviews are time consuming, both for the 
participant and the researcher. Although the researcher attempted to make every effort to try 
and meet a participant in a place of their convenience and choice as well as attempted to keep 
each interview at a maximum of 25 minutes each, most people the researcher attempted to 
secure for an interview declined or kept rescheduling the meeting date as they did not have 
time to participate. This resulted in a delay in the data collection process but also resulted in a 
fewer number of participants than the researcher would have liked. A greater amount of 





However, despite this limitation, this research achieved its aim in identifying barriers to 
medication adherence amongst people with Bipolar Mood Disorder and it gave insight into 
what these barriers are from the actual people who experience them every day. The semi-
structured, face-to-face nature of the interviews allowed the researcher to probe the 
participants for more information as well as allowed the participants the comfort of being 
interviewed in a place of their choice which influenced the type of information they shared 
with the researcher, with some even sharing sensitive information such as substance use 
which helped with the richness of the results of this research.  
 
6.3.2. Generalisability of Findings  
The ability of the results of this research to be generalised to other contexts or settings was 
affected by its few participants (6 in total). Furthermore, this research focused only on the 
barriers to medication adherence amongst people with Bipolar Mood Disorder, and as such 
the views expressed by the participants in this research may not be the same as individuals 
with other forms of mental illness. Another limitation in relation to the generalisability of the 
results of this research is that this research specifically focused on private mental health care 
users, and as such their views and experiences of barriers to medication adherence may differ 
from public mental health care users.  
 
6.3.3. Theory Driven VS Data Driven Research  
This research made use of a theory-driven approach, in which the main assumption of this 
approach is that data is given meaning when it is interpreted in relation to an existing theory 
(The Verbose Stoic, 2014). The data collected in a research study can either confirm or 
invalidate the theory being employed. In this research, the Theory of Reasoned Action and 
the Theory of Planned Behaviour were used to place the data collected from the participants 
into context. In comparison, a data-driven approach is focused on gathering large amounts of 
data, from which a theory is then generated based on that data. A limitation to the use of a 
theory-driven approach is that the theory employed guides the type of data collected, whereas 
a data-driven approach often gathers more data. As such, the theory-driven approach used in 
this research may have hindered the ability for more aspects regarding medication non-





6.4. Recommendations for Further Research 
 
This research uncovered certain areas in relation to medication non-adherence which may 
benefit from further exploration. These include:  
 
 Private VS Public mental health care sector 
This research contained participants who were all private sector mental health care users. 
Despite having access to benefits such as medical aid and private treatment, the participants 
in this research still experienced service difficulties such as payment problems related to their 
medical aid schemes as well as a lack of proper psychoeducation regarding their mental 
illness and medications from their mental health care practitioner. As such, it would be 
interesting to explore the experiences of mental health care users in the public sector and 
perhaps compare their experiences with those in the private sector and evaluate what areas in 
both of these sectors need targeting in order to better the treatment of mental health care 
users. 
  
 Lack of psychoeducation from mental health care practitioners and its impact on the 
prognosis of people with mental illness.   
An important theme which emerged from this research was how poor psychoeducation 
regarding diagnosis and medication impaired the participant’s insight and thus their 
adherence to their medication. It would be beneficial to further explore how else the lack of 
proper psychoeducation from a mental health care practitioner can impact on the mental 
health and prognosis of people with mental illness.  
 
 A qualitative exploration of the barriers to adherence to psychotropic medication in 
other mental illness diagnoses 
This research specifically focused on Bipolar Mood Disorder due to its difficult treatment 
regimen and types of medications used, however, it would also be beneficial to explore some 
of the barriers to medication adherence within other diagnoses such as Schizophrenia. A 





medication non-adherence thus far have been quantitative and it is necessary to explore the 
personal experiences of mentally ill regarding their treatment regimens.  
 Non-adherence to other forms of treatment such as psychotherapy  
The aim of this research was to explore barriers to pharmacological treatments amongst 
people with Bipolar Mood Disorder, however, there are other aspects of treatment other than 
medication including individual therapy, group therapy and even electroconvulsive therapy. 
The barriers which result in non-adherence to these other forms of treatment may contribute 
more information regarding the nature of non-adherence to treatment amongst the mentally 
ill.  
 
 Perceived State of Detachment  
Within this research, 50% of respondents reported that they often do not “feel like 
themselves”. This outcome/symptom should be explored further in future research. It is 
not quite clear as to what was implied by this response in this research, however what was 
apparent was a sense of ‘detachment’ from the premorbid sense of self. 
 
 Legitimacy of Information Acquired via Online Websites by Patients with Mental 
Illness and its Impact on Anxiety Reduction 
Whilst it was not the scope of the current research, it would be useful if future research 
was able to identify the legitimacy of information acquired via online websites so as to 
assess the nature of information searched for and whether this information contributes to 
a reduction in patient anxiety and whether the perception of the meaningfulness of this 
information reduces patient anxiety. 
 
6.5. Self-Reflection 
This research topic was chosen due to the researcher’s personal experience with a loved one 
regarding her own difficulties with non-adherence to psychotropic medication. This was 
something that the researcher did not fully understand, as she could not comprehend why 
someone would stop taking something which was supposed to make them feel mentally well. 





chronic medications daily for severe mental illness and try to see from their perspective what 
some of the contributing factors are which result in non-adherence.  
This research allowed the researcher the opportunity to see that non-adherence is multifaceted 
and is impacted by so many factors other than the mental illness itself. The mentally ill in 
South Africa and globally seem to face barriers at every point of their treatment, from 
medications which make them feel physically ill every day, to problems with service 
delivery, to family and societal pressure and stigma which places pressure on them to want to 
be “normal”. The researcher felt that this research helped in not only being able enter the 
world of people with Bipolar Mood Disorder and identify their difficulties with psychotropic 
treatment regimens and the mental health care system in South Africa, but it has also 
expanded the researchers’ empathy towards the daily struggles faced by people with mental 
illness and the strength and resilience they have to continue to try and fight these barriers.  
 
To conclude, the researcher would like to end with a quote from a famous Bipolar Mood 
Disorder sufferer, Carrie Fisher:  
 
“I’m fine, but I’m Bipolar. I’m on seven medications, and I take medication three times a 
day. This constantly puts me in touch with the illness I have. I’m never quite allowed to be 
free of that for a day.”  
- Carrie Fisher 
(BP Magazine, 2016).  
  
6.6. Summary of Chapter  
This chapter included a short summary and conclusion of the results of this research as well 
as the limitations of this study, followed by some recommendations for future research. This 
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APPENDIX 1 – SEMI-STRUCTURED INTERVIEW SCHEDULE:  
 
a) Interview Questions  
 Screening Question 
  
Have you missed a dose of your medication for the treatment of major depression/ Bipolar 
Disorder in the past week and/ or have you missed three or more doses of your medication in 





(Please note that the following questions are the structured questions for the interview and 
that unstructured questions and probes may be used where applicable in each individual 
interview. Examples of probing questions have been supplied herewith)  
 
General Questioning 
1. Could you please tell me a little about yourself?  
**Probe: Current age 
   Marital/relationship status 
   Highest level of education 
  Currently employment status 
  Diagnosis 





2. How long have you been on treatment (medication and/or psychotherapy)? 
 
3. In the past month how many times have you missed taking your medication?  
*Probe: Which ones and for what period of time where they not taken 
 
Core Theme: Perceived Barriers (Side effects, socio-economic factors etc.) 
 
4. What would you say was the reason for not taking your prescribed medication? 
*Probe: availability, cost, side-effects, illness/wellness, not remembering, 
vegetative          shifts, other – use of alcohol/substances etc.) 
 
5. In the past year how many times were you admitted for inpatient treatment due to 
your mental state?   
*Probe: do you think this may have been due to not taking certain 
medications, loss of treatment efficacy, manic state, depressed state, other 
side-effects or illness states) 
 
Core Theme: Behavioural Beliefs and Attitude toward the Behaviour  
 
6. Describe medication and/or psychotherapy treatment regimen – times of day taking 
meds 
*Probe: Which medications are you/ have you taken? 
  How many pills for Bipolar Disorder do you take per day?  
 
7. a) Are you aware of and understand the necessity of taking your medication?  






*Probe: Did your mental health care practitioner 
explicitly explain to you the importance of taking your 
medications as prescribed?  
*Probe: When you are adherent to your medication 
regimen, how do you feel in terms of wellness? 
*Probe: When you have not taken your medication, how 
do you feel in terms of wellness?   
*Probe: When you are well, do you feel that your 
medication is important to take as prescribed by your 
practitioner?  
*Probe: When you are unwell, do you feel that your 
medication is important to take as prescribed by your 
practitioner?  
 
Core Theme: Self-Efficacy and Cues to Action 
 
8. Did you do any of your own personal research regarding your diagnosis as well as the 
importance involved in taking your medications as prescribed?  
*Probe: What did you learn?  
 
9. What do you think may help you keep track of and encourage you to take your 
medication at the correct time and dosages?  
 
General Questioning 
10. Did you find this interview and its questions understandable?  
  
a) If you responded no, please specify where you encountered a problem. 
 





APPENDIX 2 – CONSENT FORMS 
 
  School of Applied Human Sciences 
Discipline Psychology 
College of Humanities 
University of KwaZulu-Natal 
Howard College Campus 
 Durban, South Africa 
 
 




A qualitative study exploring the dynamics of patient adherence to psychotropic medication 




I am a Masters’ student in Clinical Psychology at the University of KwaZulu-Natal (Howard 
Campus). I am required to do a research dissertation as part of my training. My research is on 
the dynamics of client adherence to psychotropic medication use amongst adult patients with 
Bipolar Disorder.  
 
Research is just the process to learn the answer to a question.  
 
You are being invited to consider participating in a study that involves research to aid in 
understanding dynamics experienced by individuals leading to difficulty in adhering to 
prescribed medication. The purpose of this research is to identify these factors that hinder 





The study involves the single administration of an interview which will first consist of a 
section on biographical information. Thereafter, a set of semi-structured questions and 
possibly others if necessary will be asked relating to your Bipolar Disorder and the 
medication you take for its maintenance. It should take about 15 minutes for you to answer 
the questions I will be asking you. 
Your answers will be recorded on a prepared questionnaire sheet; however, the interview will 
be recorded using an electronic device for the purpose of documenting your true thoughts and 
ideas and to ensure that none of the results of this study are fabricated. 
The study will not provide any direct benefits to you, the participant, but it will help in 
gaining more knowledge on the dynamics that hinder adherence experienced by Bipolar 
Disorder clients. 
Participation in this research is strictly voluntary and you may withdraw your participation at 
any point of the study. 
 
Participants will not be asked to provide their name or address. All of the information that you 
provide will be kept confidential and anonymous. When working with the information 
provided, participants will be assigned numbers to ensure that confidentiality and anonymity 
is upheld. 
 
The researcher will be available to discuss any issues or concerns that you may have as they 
arise. Confidentiality of your personal/ clinical information will be protected at all times.   
 
In the event of any problems or concerns/ questions, you may contact the researcher or the 
supervisor of the study, Mr Sachet Valjee. 
If you have any queries regarding the rights of research respondents, please contact Ms. 
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Information Sheet (isiZulu):  
 
  School of Applied Human Sciences 
Discipline Psychology 
College of Humanities 
University of KwaZulu-Natal 
Howard College Campus 





Ikhasi Elinolwazi Oludingayo 
Ucwaningo olulandela umgudu we-qualitative study olumayelana nokwehluka kwezindlela 
iziguli esezikhulile ezamukela ngayo uhlelo lokwelashwa kwesifo esibizwa nge- Bipolar 




Ngingumfundi owenza iziqu ze-Masters in Clinical Psychology enyuvesi yaKwaZulu-Natal 
(Howard Campus). Kufanele ngenze ucwaningo njengengxenye yokuqeqeshwa kwami. 
Ucwaningo lwami lumayelana nokwehluka kwezindlela iziguli esezikhulile ezamukela ngayo 
uhlelo lokwelashwa kwesifo esibizwa nge- Bipolar kusetshenziswa ubuchwepheshe 
bemishanguzo yengqondo. 
 
Ucwaningo luyindlela yokufunda ukuphendula imibuzo. 
 
Uyamenywa ukuba ube yingxenye yabazobamba iqhaza kulolu cwaningo oluhlanganisa ukusiza 







Inhloso yalolu cwaningo ukuveza izinto eziyizingqinamba bese kuvezwa nezinhlelo zokusiza. 
Ucwaningo luhlanganisa ne-inthaviyu yomuntu ngamunye ehambisana nolwazi ngaye. Emva 
kwalokho, kunemibuzo ehleliwe neminye engaqhamuka uma kunesidingo, ehambisa ne- Bipolar 
Disorder kanye nemithi ethathwayo ukuze ukwazi ukuyithiba. Kufanele kuthathe imizuzu engu-
15 ukuphendula imibuzo engizokubuza yona. 
 
Izimpendulo zakho zizobhalwa ephepheni lemibuzo yenhlolovo elungisiwe, kodwa, le- 
inthaviyu izoqoshwa ngesiqophamazwi ngenhloso yokugcina imicabango nemibono yakho 
eyiqiniso nokuthi ingabi bikho imiphumela yalolu cwaningo engelona iqiniso. 
Ucwaningo aluzoba nanzuzo kuwena njengomhlanganyeli kulo kodwa luzokusiza uthole ulwazi 
oluningi ngezinkinga ezihlangabezana neziguli ze-Bipolar Disorder. 
 
Abukho ubungozi ekubambeni iqhaza kulolu cwaningo. 
 
Ukubamba iqhaza kulolu cwaningo akuphoqiwe nhlobo futhi ungahoxa ekubambeni iqhaza 
noma inini. Uma ukhetha ukuba ukubamba iqhaza uzokhokhelwa ngesikhathi sakho osichithile 
kulolu cwaningo. 
 
Ababamba iqhaza ngeke bacelwe amagama noma amakheli abo.  Konke ozokukhuluma 
kuzogcinwa ngendlela eyimfihlo futhi kungazi muntu ngakho. Uma sekusetshenzwa ngolwazi 
olunikeziwe, abahlanganyeli balolu cwaningo bazonikezwa izinombolo ezizoqinisekisa ukuthi 
akuzukwaziwa ukuthi luphuma kubo. 
 
Umcwaningi uzohlale etholakala kalula ukuxoxa noma yingani engaqhamuka. Imininingwane 
ngawe nolwazi olunikezile kuzoba yimfihlo ezovikelela ngaso sonke isikhathi. Uma 
kunezinkinga noma imibuzo, ungathintana nomcwaningi noma u-Supervisor walolu cwaningo, 
uMnu. Sachet Valjee. Uma kuneminye imibuzo ephathelene namalungelo akho ngalolu 
cwaningo ngicela uthinte u Nksz. Phumelele Ximba osehhovisi le- Humanities and Social 
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APPENDIX 3 - Declaration of Informed Consent (English): 
 
I have been informed about the study entitled “A qualitative study exploring the dynamics of 
client adherence to psychotropic medication use amongst adult patients with Bipolar Disorder”. 
 
I have received, read and understood the written information about the study. 
 
I understand everything that has been explained to me. 
 
I understand the purpose and procedures of the study.  
 
I have been given an opportunity to ask questions about the study and have had answers to my 
satisfaction. 
 
I understand and declare that my participation in this study is entirely voluntary and that I may 
withdraw at any time and that the information that I provide will be anonymous and 
confidential and will only be used for research purposes.  
 
I hereby consent/ do not consent to have this interview recorded.  
 
If I have any further questions/ concerns or queries related to the study I understand that I may 
contact the researcher, supervisor or ethics administrator.  
 
If I have any questions or concerns about my right as a study participant, or if I am concerned 
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Declaration of Informed Consent (isiZulu):  
 
Isiqinisekiso Sokwaziswa Ngocwaningo: 
 
Ngazisiwe ngocwaningo olumayelana “Nokwehluka kwezindlela iziguli esezikhulile 
ezamukela ngayo uhlelo lokwelashwa kwesifo esibizwa nge- Bipolar kusetshenziswa 
ubuchwepheshe bemishanguzo yengqondo” 
 
Ngiyitholile, ngayifunda futhi ngayiqonda imininingwane ebhalwe phansi ngalolu cwaningo. 
 
Ngiyakuqonda konke engikuchazeliwe.  
 
Ngiyayiqonda inhloso nenqubo elandelwayo uma kwenziwa ucwaningo. 
 
Nginikiwe ithuba lokubuza imibuzo ngocwaningo futhi ngathola izimpendulo ezingigculisile. 
 
Ngiyaqonda futhi ngiyaqinisekisa ukuthi ukubamba iqhaza kwami kulolu cwaningo 
akuphoqiwe nokuthi ngingahoxa noma nini nanokuthi ulwazi engilunikezayo aluzuveza igama 
lami futhi luzosetshenziselwa ucwaningo kuphela. 
 
Nginika imvume/ Angivumi ukuba le-inthaviyu iqoshwe. 
 
Uma ngineminye imibuzo/ imibono noma izikhalo eziphathelene nocwaningo ngiyaqonda 
ukuthi ngingathinta umcwaningi, u-supervisor noma abaphethe kulo mnyango. 
 
Uma nginemibuzo noma izikhalo ngelungelo lami njengobambe iqhaza kulolu cwaningo, noma 
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APPENDIX 5 - Gatekeepers Letter 
 
 
 
 
 
 
